The locus coeruleus-noradrenergic system: Modulation of behavioral state and state-dependent cognitive processes

Brain Research Reviews

Volumn 42, Issue 1, 2003, Pages 33-84

  Berridge, Craig W ^a   Waterhouse, Barry D ^b  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

Amphetamine; Arousal; Attention; Cognition; Learning; Memory; Norepinephrine; Perception; Sensory; Sleep; Stimulants; Stress; Vigilance; Waking

Indexed keywords

ADRENALIN; ADRENERGIC RECEPTOR; ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; AMPHETAMINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETHANECHOL; CATECHOLAMINE; CHOLINERGIC RECEPTOR STIMULATING AGENT; COCAINE; CORTICOTROPIN RELEASING FACTOR ANTAGONIST; DESIPRAMINE; GLUCOCORTICOID; GUANFACINE; KYNURENIC ACID; METHYLPHENIDATE; NORADRENALIN; OREXIN; PEPTIDE; STEROID;

ALERTNESS; AMYGDALOID NUCLEUS; AROUSAL; ATTENTION; ATTENTION DEFICIT DISORDER; AVERSIVE BEHAVIOR; BEHAVIOR; BRAIN CORTEX; BRAIN FUNCTION; COGNITION; CONCENTRATION RESPONSE; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; EFFERENT NERVE; ELECTROENCEPHALOGRAM; ELECTROPHYSIOLOGY; EMOTION; EVENT RELATED POTENTIAL; FOREBRAIN; GENETIC TRANSCRIPTION; HUMAN; INSOMNIA; LOCUS CERULEUS; MEDIAL PREOPTIC AREA; MEMORY DISORDER; MENTAL DISEASE; MOOD DISORDER; MOTOR PERFORMANCE; MUTATION; NARCOLEPSY; NERVE CELL; NERVE CELL NETWORK; NERVE CELL PLASTICITY; NEUROCHEMISTRY; NEUROTRANSMISSION; NEUROTRANSMITTER RELEASE; NONHUMAN; NORADRENERGIC SYSTEM; PANIC; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; RECEPTIVE FIELD; RECEPTOR DENSITY; REVIEW; SENSORY NERVE; SENSORY STIMULATION; SLEEP DISORDER; SOMATOSENSORY CORTEX; STRESS; SUBSTANTIA INNOMINATA; SYNAPTIC TRANSMISSION; THALAMUS; WAKEFULNESS; WORKING MEMORY;

EID: 0037381980     PISSN: 01650173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-0173(03)00143-7     Document Type: Review

References (584)

1. Abercrombie E.D., Jacobs B.L. Single-unit response of noradrenergic neurons in the locus coeruleus of freely moving cats. I. Acutely presented stressful and nonstressful stimuli. J. Neurosci. 7:1987;2837-2843.
2. Abercrombie E.D., Jacobs B.L. Single-unit response of noradrenergic neurons in the locus coeruleus of freely moving cats. II. Adaptation to chronically presented stressful stimuli. J. Neurosci. 7:1987;2844-2848.
3. Abercrombie E.D., Keller R.W. Jr., Zigmond M.J. Characterization of hippocampal norepinephrine release as measured by microdialysis perfusion: pharmacological and behavioral studies. Neuroscience. 27:1988;897-904.
4. Abercrombie E.D., Zigmond M.J. Partial injury to central noradrenergic neurons: reduction of tissue norepinephrine content is greater than reduction of extracellular norepinephrine measured by microdialysis. J. Neurosci. 9:1989;4062-4067.
5. Adams L.M., Foote S.L. Effects of locally infused pharmacological agents on spontaneous and sensory-evoked activity of locus coeruleus neurons. Brain Res. Bull. 21:1988;395-400.
6. Aghajanian G.K. Tolerance of locus coeruleus neurones to morphine and suppression of withdrawal response by clonidine. Nature. 276:1978;186-188.
7. Agren H. Clonidine treatment of the opiate withdrawal syndrome. A review of clinical trials of a theory. Acta Psychiatr. Scand. Suppl. 327:1986;91-113.
8. Akaoka H., Aston-Jones G. Opiate withdrawal-induced hyperactivity of locus coeruleus neurons is substantially mediated by augmented excitatory amino acid input. J. Neurosci. 11:1991;3830-3839.
9. Alvarez-Maubecin V., Garcia-Hernandez F., Williams J.T., Van Bockstaele E.J. Functional coupling between neurons and glia. J. Neurosci. 20:2000;4091-4098.
10. Amaral D.G., Sinnamon H.M. The locus coeruleus: neurobiology of a central noradrenergic nucleus. Prog. Neurobiol. 9:1977;147-196.
11. Anand A., Charney D.S. Norepinephrine dysfunction in depression. J. Clin. Psychiatry. 61:(Suppl. 10):2000;16-24.
12. Anisman H. Neurochemical changes elicited by stress. Anisman H., Bignami G. Psychopharmacology of Aversively Motivated Behavior. 1978;119-172 Plenum Press, New York.
13. Aoki C. Beta-adrenergic receptors: astrocytic localization in the adult visual cortex and their relation to catecholamine axon terminals as revealed by electron microscopic immunocytochemistry. J. Neurosci. 12:1992;781-792.
14. Armstrong-James M., Fox K. Effects of ionophoresed noradrenaline on the spontaneous activity of neurones in rat primary somatosensory cortex. J. Physiol. 335:1983;427-447.
15. Arnsten A.F. Catecholamine regulation of the prefrontal cortex. J. Psychopharmacol. 11:1997;151-162.
16. Arnsten A.F. Modulation of prefrontal cortical-striatal circuits: relevance to therapeutic treatments for Tourette syndrome and attention-deficit hyperactivity disorder. Adv. Neurol. 85:2001;333-341.
17. Arnsten A.F., Cai J.X., Goldman-Rakic P.S. The alpha-2 adrenergic agonist guanfacine improves memory in aged monkeys without sedative or hypotensive side effects: evidence for alpha-2 receptor subtypes. J. Neurosci. 8:1988;4287-4298.
18. Arnsten A.F., Contant T.A. Alpha-2 adrenergic agonists decrease distractibility in aged monkeys performing the delayed response task. Psychopharmacology (Berl.). 108:1992;159-169.
19. Arnsten A.F., Goldman-Rakic P.S. Selective prefrontal cortical projections to the region of the locus coeruleus and raphe nuclei in the rhesus monkey. Brain Res. 306:1984;9-18.
20. Arnsten A.F., Goldman-Rakic P.S. Alpha 2-adrenergic mechanisms in prefrontal cortex associated with cognitive decline in aged nonhuman primates. Science. 230:1985;1273-1276.
21. Arnsten A.F., Goldman-Rakic P.S. Catecholamines and cognitive decline in aged nonhuman primates. Ann. N.Y. Acad. Sci. 444:1985;218-234.
22. Arnsten A.F., Goldman-Rakic P.S. Analysis of alpha-2 adrenergic agonist effects on the delayed nonmatch-to-sample performance of aged rhesus monkeys. Neurobiol. Aging. 11:1990;583-590.
23. Arnsten A.F., Goldman-Rakic P.S. Noise stress impairs prefrontal cortical cognitive function in monkeys: evidence for a hyperdopaminergic mechanism. Arch. Gen. Psychiatry. 55:1998;362-368.
24. Arnsten A.F., Mathew R., Ubriani R., Taylor J.R., Li B.M. Alpha-1 noradrenergic receptor stimulation impairs prefrontal cortical cognitive function. Biol. Psychiatry. 45:1999;26-31.
25. Arnsten A.F., Segal D.S., Loughlin S.E., Roberts D.C. Evidence for an interaction of opioid and noradrenergic locus coeruleus systems in the regulation of environmental stimulus-directed behavior. Brain Res. 222:1981;351-363.
26. Arnsten A.F., Steere J.C., Hunt R.D. The contribution of alpha 2-noradrenergic mechanisms of prefrontal cortical cognitive function. Potential significance for attention-deficit hyperactivity disorder. Arch. Gen. Psychiatry. 53:1996;448-455.
27. Aston-Jones G., Bloom F.E. Activity of norepinephrine-containing locus coeruleus neurons in behaving rats anticipates fluctuations in the sleep-waking cycle. J. Neurosci. 1:1981;876-886.
28. Aston-Jones G., Bloom F.E. Norepinephrine-containing locus coeruleus neurons in behaving rats exhibit pronounced responses to non-noxious environmental stimuli. J. Neurosci. 1:1981;887-900.
29. Aston-Jones G., Ennis M., Pieribone V.A., Nickell W.T., Shipley M.T. The brain nucleus locus coeruleus: restricted afferent control of a broad efferent network. Science. 234:1986;734-737.
30. Aston-Jones G., Hirata H., Akaoka H. Local opiate withdrawal in locus coeruleus in vivo. Brain Res. 765:1997;331-336.
31. Aston-Jones G., Rajkowski J., Ivanova S., Usher M., Cohen J. Neuromodulation and cognitive performance: recent studies of noradrenergic locus ceruleus neurons in behaving monkeys. Adv. Pharmacol. 42:1998;755-759.
32. Aston-Jones G., Rajkowski J., Kubiak P. Conditioned responses of monkey locus coeruleus neurons anticipate acquisition of discriminative behavior in a vigilance task. Neuroscience. 80:1997;697-715.
33. Aston-Jones G., Rajkowski J., Kubiak P., Alexinsky T. Locus coeruleus neurons in monkey are selectively activated by attended cues in a vigilance task. J. Neurosci. 14:1994;4467-4480.
34. Aston-Jones G., Segal M., Bloom F.E. Brain aminergic axons exhibit marked variability in conduction velocity. Brain Res. 195:1980;215-222.
35. Bach-y-Rita P. Nonsynaptic Diffusion Neurotransmission and Late Brain Reorganization. 1995;Demos, New York.
36. Barker E.L., Blakely R.D. Physiological determinants of locus coeruleus discharge. Bloom F.E., Kupfer D.J. The Fourth Generation of Progress. 1995;321-334 Raven Press, New York.
37. Barnes C.A., Pompeiano M. Neurobiology of the locus coeruleus. Prog. Brain Res. 88:1991;307-321.
38. Bartus R.T. Four stimulants of the central nervous system: effects on short-term memory in young versus aged monkeys. J. Am. Geriatr. Soc. 27:1979;289-297.
39. Bean A.J., Roth R.H. Extracellular dopamine and neurotensin in rat prefrontal cortex in vivo: effects of median forebrain bundle stimulation frequency, stimulation pattern, and dopamine autoreceptors. J. Neurosci. 11:1991;2694-2702.
40. Bekavac I., Waterhouse B.D. Systemically administered cocaine selectively enhances long-latency responses of rat barrel field cortical neurons to vibrissae stimulation. J. Pharmacol. Exp. Ther. 272:1995;333-342.
41. Berridge C.W., Abercrombie E.D. Relationship between locus coeruleus discharge rates and rates of norepinephrine release within neocortex as assessed by in vivo microdialysis. Neuroscience. 93:1999;1263-1270.
42. Berridge C.W., Bolen S.J., Manley M.S., Foote S.L. Modulation of forebrain electroencephalographic activity in halothane-anesthetized rat via actions of noradrenergic beta-receptors within the medial septal region. J. Neurosci. 16:1996;7010-7020.
43. Berridge C.W., Dunn A.J. Restraint-stress-induced changes in exploratory behavior appear to be mediated by norepinephrine-stimulated release of CRF. J. Neurosci. 9:1989;3513-3521.
44. Berridge C.W., Dunn A.J. DSP-4-induced depletion of brain norepinephrine produces opposite effects on exploratory behavior 3 and 14 days after treatment. Psychopharmacology (Berl.). 100:1990;504-508.
45. Berridge C.W., España R.A. Synergistic sedative effects of noradrenergic alpha(1)- and beta-receptor blockade on forebrain electroencephalographic and behavioral indices. Neuroscience. 99:2000;495-505.
46. Berridge C.W., Foote S.L. Effects of locus coeruleus activation on electroencephalographic activity in neocortex and hippocampus. J. Neurosci. 11:1991;3135-3145.
47. Berridge C.W., Foote S.L. Enhancement of behavioral and electroencephalographic indices of waking following stimulation of noradrenergic beta-receptors within the medial septal region of the basal forebrain. J. Neurosci. 16:1996;6999-7009.
48. 1- and β-receptor stimulation, Behav. Neurosci. (2003) in press.
49. Berridge C.W., Morris M.F. Amphetamine-induced activation of forebrain EEG is prevented by noradrenergic beta-receptor blockade in the halothane-anesthetized rat. Psychopharmacology (Berl.). 148:2000;307-313.
50. Berridge C.W., O'Neil J., Wifler K. Amphetamine acts within the medial basal forebrain to initiate and maintain alert waking. Neuroscience. 93:1999;885-896.
51. Berridge C.W., O'Neill J. Differential sensitivity to the wake-promoting actions of norepinephrine within the medial preoptic area and the substantia innominata. Behav. Neurosci. 115:2001;165-174.
52. Berridge C.W., Page M.E., Valentino R.J., Foote S.L. Effects of locus coeruleus inactivation on electroencephalographic activity in neocortex and hippocampus. Neuroscience. 55:1993;381-393.
53. Berridge C.W., Stalnaker T.A. Relationship between low-dose amphetamine-induced arousal and extracellular norepinephrine and dopamine levels within prefrontal cortex. Synapse. 46:2002;140-149.
54. Berridge C.W., Stratford T.L., Foote S.L., Kelley A.E. Distribution of dopamine beta-hydroxylase-like immunoreactive fibers within the shell subregion of the nucleus accumbens. Synapse. 27:1997;230-241.
55. Berridge C.W., Wifler K. Contrasting effects of noradrenergic beta-receptor blockade within the medial septal area on forebrain electroencephalographic and behavioral activity state in anesthetized and unanesthetized rat. Neuroscience. 97:2000;543-552.
56. Bicknell R.J. Optimizing release from peptide hormone secretory nerve terminals. J. Exp. Biol. 139:1988;51-65.
57. Bicknell R.J., Leng G. Relative efficiency of neural firing patterns for vasopressin release in vitro. Neuroendocrinology. 33:1981;295-299.
58. Biederman J., Spencer T. Attention-deficit/hyperactivity disorder (ADHD) as a noradrenergic disorder. Biol. Psychiatry. 46:1999;1234-1242.
59. Bing G., Stone E.A., Zhang Y., Filer D. Immunohistochemical studies of noradrenergic-induced expression of c-fos in the rat CNS. Brain Res. 592:1992;57-62.
60. Bing G.Y., Filer D., Miller J.C., Stone E.A. Noradrenergic activation of immediate early genes in rat cerebral cortex. Brain Res. Mol. Brain Res. 11:1991;43-46.
61. Birnbaum S., Gobeske K.T., Auerbach J., Taylor J.R., Arnsten A.F. A role for norepinephrine in stress-induced cognitive deficits: alpha-1-adrenoceptor mediation in the prefrontal cortex. Biol. Psychiatry. 46:1999;1266-1274.
62. Blanc G., Trovero F., Vezina P., Herve D., Godeheu A.M., Glowinski J., Tassin J.P. Blockade of prefronto-cortical alpha 1-adrenergic receptors prevents locomotor hyperactivity induced by subcortical D-amphetamine injection. Eur. J. Neurosci. 6:1994;293-298.
63. Bloor B.C., Flacke W.E. Reduction in halothane anesthetic requirement by clonidine, an alpha-adrenergic agonist. Anesth. Analg. 61:1982;741-745.
64. Borsody M.K., Weiss J.M. Influence of corticotropin-releasing hormone on electrophysiological activity of locus coeruleus neurons. Brain Res. 724:1996;149-168.
65. Bourgin P., Huitron-Resendiz S., Spier A.D., Fabre V., Morte B., Criado J.R., Sutcliffe J.G., Henriksen S.J., de Lecea L. Hypocretin-1 modulates rapid eye movement sleep through activation of locus coeruleus neurons [In Process Citation]. J. Neurosci. 20:2000;7760-7765.
66. Boyajian C.L., Leslie F.M. Pharmacological evidence for alpha-2 adrenoceptor heterogeneity: differential binding properties of [3H]rauwolscine and [3H]idazoxan in rat brain. J. Pharmacol. Exp. Ther. 241:1987;1092-1098.
67. Bremner J.D., Krystal J.H., Southwick S.M., Charney D.S. Noradrenergic mechanisms in stress and anxiety: II. Clinical studies. Synapse. 23:1996;39-51.
68. Browning M.D., Bureau M., Dudek E.M., Olsen R.W. Protein kinase C and cAMP-dependent protein kinase phosphorylate the beta subunit of the purified gamma-aminobutyric acid A receptor. Proc. Natl. Acad. Sci. U.S.A. 87:1990;1315-1318.
69. Brozoski T.J., Brown R.M., Rosvold H.E., Goldman P.S. Cognitive deficit caused by regional depletion of dopamine in prefrontal cortex of rhesus monkey. Science. 205:1979;929-932.
70. Bushnell M.C., Goldberg M.E., Robinson D.L. Behavioral enhancement of visual responses in monkey cerebral cortex. I. Modulation in posterior parietal cortex related to selective visual attention. J. Neurophysiol. 46:1981;755-772.
71. Butler P.D., Weiss J.M., Stout J.C., Nemeroff C.B. Corticotropin-releasing factor produces fear-enhancing and behavioral activating effects following infusion into the locus coeruleus. J. Neurosci. 10:1990;176-183.
72. Buzsaki G., Bickford R.G., Ponomareff G., Thal L.J., Mandel R., Gage F.H. Nucleus basalis and thalamic control of neocortical activity in the freely moving rat. J. Neurosci. 8:1988;4007-4026.
73. Buzsaki G., Kennedy B., Solt B.V., Ziegler M. Noradrenergic control of thalamic oscillation: the role of α-2 receptors. Eur. J. Neurosci. 3:1991;222-229.
74. Buzsaki G., Leung L.W., Vanderwolf C.H. Cellular bases of hippocampal EEG in the behaving rat. Brain Res. 287:1983;139-171.
75. Byck R., Van Dyke C. What are the effects of cocaine in man? NIDA Res. Monogr Series. 13:1977;97-117.
76. Bylund D.B., Blaxall H.S., Iversen L.J., Caron M.G., Lefkowitz R.J., Lomasney J.W. Pharmacological characteristics of alpha 2-adrenergic receptors: comparison of pharmacologically defined subtypes with subtypes identified by molecular cloning. Mol. Pharmacol. 42:1992;1-5.
77. Cahill L., Prins B., Weber M., McGaugh J.L. Beta-adrenergic activation and memory for emotional events. Nature. 371:1994;702-704.
78. Cai J.X., Ma Y.Y., Xu L., Hu X.T. Reserpine impairs spatial working memory performance in monkeys: reversal by the alpha 2-adrenergic agonist clonidine. Brain Res. 614:1993;191-196.
79. Cape E.G., Jones B.E. Differential modulation of high-frequency gamma-electroencephalogram activity and sleep-wake state by noradrenaline and serotonin microinjections into the region of cholinergic basalis neurons. J. Neurosci. 18:1998;2653-2666.
80. Carli M., Robbins T.W., Evenden J.L., Everitt B.J. Effects of lesions to ascending noradrenergic neurones on performance of a 5-choice serial reaction task in rats; implications for theories of dorsal noradrenergic bundle function based on selective attention and arousal. Behav. Brain Res. 9:1983;361-380.
81. Castaneda E., Whishaw I.Q., Robinson T.E. Changes in striatal dopamine neurotransmission assessed with microdialysis following recovery from a bilateral 6-OHDA lesion: variation as a function of lesion size. J. Neurosci. 10:1990;1847-1854.
82. Castellanos F.X. Neuroimaging studies of ADHD. Solanto M.V Arnsten A.F.T., Castellanos F.X. Stimulant Drugs and ADHD: Basic and Clinical Neuroscience. 2001;243-282 Oxford University Press, New York.
83. Cedarbaum J.M., Aghajanian G.K. Afferent projections to the rat locus coeruleus as determined by a retrograde tracing technique. J. Comp. Neurol. 178:1978;1-16.
84. Chappell P.B., Riddle M.A., Scahill L., Lynch K.A., Schultz R., Arnsten A., Leckman J.F., Cohen D.J. Guanfacine treatment of comorbid attention-deficit hyperactivity disorder and Tourette's syndrome: preliminary clinical experience. J. Am. Acad. Child Adolesc. Psychiatry. 34:1995;1140-1146.
85. Charney D.S., Heninger G.R., Redmond D.E. Jr. Yohimbine induced anxiety and increased noradrenergic function in humans: effects of diazepam and clonidine. Life Sci. 33:1983;19-29.
86. Charney D.S., Heninger G.R., Sternberg D.E., Redmond D.E., Leckman J.F., Maas J.W., Roth R.H. Presynaptic adrenergic receptor sensitivity in depression. The effect of long-term desipramine treatment. Arch. Gen. Psychiatry. 38:1981;1334-1340.
87. Chaulk P.C., Harley C.W. Intracerebroventricular norepinephrine potentiation of the perforant path-evoked potential in dentate gyrus of anesthetized and awake rats: A role for both alpha- and beta-adrenoceptor activation. Brain Res. 787:1998;59-70.
88. Chemelli R.M., Willie J.T., Sinton C.M., Elmquist J.K., Scammell T., Lee C., Richardson J.A., Williams S.C., Xiong Y., Kisanuki Y., Fitch T.E., Nakazato M., Hammer R.E., Saper C.B., Yanagisawa M. Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation [see comments]. Cell. 98:1999;437-451.
89. Cheun J.E., Yeh H.H. Modulation of GABAA receptor-activated current by norepinephrine in cerebellar Purkinje cells. Neuroscience. 51:1992;951-960.
90. Cheun J.E., Yeh H.H. Noradrenergic potentiation of cerebellar Purkinje cell responses to GABA: cyclic AMP as intracellular intermediary. Neuroscience. 74:1996;835-844.
91. Chikamori Y., Sasa M., Fujimoto S., Takaori S., Matsuoka I. Locus coeruleus-induced inhibition of dorsal cochlear nucleus neurons in comparison with lateral vestibular nucleus neurons. Brain Res. 194:1980;53-63.
92. Christianson S.A. Emotional stress and eyewitness memory: a critical review. Psychol. Bull. 112:1992;284-309.
93. Christie M.J. Mechanisms of opioid actions on neurons of the locus coeruleus. Prog. Brain Res. 88:1991;197-205.
94. Christie M.J., Jelinek H.F. Dye-coupling among neurons of the rat locus coeruleus during postnatal development. Neuroscience. 56:1993;129-137.
95. Christie M.J., Williams J.T., North R.A. Electrical coupling synchronizes subthreshold activity in locus coeruleus neurons in vitro from neonatal rats. J. Neurosci. 9:1989;3584-3589.
96. Christie M.J., Williams J.T., Osborne P.B., Bellchambers C.E. Where is the locus in opioid withdrawal? Trends Pharmacol. Sci. 18:1997;134-140.
97. Ciombor K.J., Ennis M., Shipley M.T. Norepinephrine increases rat mitral cell excitatory responses to weak olfactory nerve input via alpha-1 receptors in vitro. Neuroscience. 90:1999;595-606.
98. Cirelli C., Pompeiano M., d'Ascanio P., Arrighi P., Pompeiano O. c-fos Expression in the rat brain after unilateral labyrinthectomy and its relation to the uncompensated and compensated stages. Neuroscience. 70:1996;515-546.
99. Cirelli C., Tononi G. Changes in anti-phosphoserine and anti-phosphothreonine antibody binding during the sleep-waking cycle and after lesions of the locus coeruleus. Sleep Res. Online. 1:1998;11-18.
100. Cirelli C., Tononi G. Differential expression of plasticity-related genes in waking and sleep and their regulation by the noradrenergic system. J. Neurosci. 20:2000;9187-9194.
101. Clark C.R., Geffen G.M., Geffen L.B. Catecholamines and attention. I: Animal and clinical studies. Neurosci. Biobehav. Rev. 11:1987;341-352.
102. Clark C.R., Geffen G.M., Geffen L.B. Catecholamines and the covert orientation of attention in humans. Neuropsychologia. 27:1989;131-139.
103. Clark F.M., Proudfit H.K. The projection of noradrenergic neurons in the A7 catecholamine cell group to the spinal cord in the rat demonstrated by anterograde tracing combined with immunocytochemistry. Brain Res. 547:1991;279-288.
104. Clavier R.M. Afferent projections to the self-stimulation regions of the dorsal pons, including the locus coeruleus, in the rat as demonstrated by the horseradish peroxidase technique. Brain Res. Bull. 4:1979;497-504.
105. Clayton E.C., Williams C.L. Posttraining inactivation of excitatory afferent input to the locus coeruleus impairs retention in an inhibitory avoidance learning task. Neurobiol. Learn. Mem. 73:2000;127-140.
106. Cohen S. Recent developments in the abuse of cocaine. Bull. Narc. 36:1984;3-14.
107. Collier T.J., Gash D.M., Sladek J.R. Jr. Transplantation of norepinephrine neurons into aged rats improves performance of a learned task. Brain Res. 448:1988;77-87.
108. Collins G.G., Probett G.A., Anson J., McLaughlin N.J. Excitatory and inhibitory effects of noradrenaline on synaptic transmission in the rat olfactory cortex slice. Brain Res. 294:1984;211-223.
109. Collins P., Roberts A.C., Dias R., Everitt B.J., Robbins T.W. Perseveration and strategy in a novel spatial self-ordered sequencing task for nonhuman primates. Effects of excitotoxic lesions and dopamine depletions of the prefrontal cortex. J. Cogn. Neurosci. 10:1998;332-354.
110. Connors B.W., Gutnick M.J. Intrinsic firing patterns of diverse neocortical neurons. Trends Neurosci. 13:1990;99-104.
111. Connors B.W., Gutnick M.J., Prince D.A. Electrophysiological properties of neocortical neurons in vitro. J. Neurophysiol. 48:1982;1302-1320.
112. Conti L.H., Foote S.L. Reciprocal cross-desensitization of locus coeruleus electrophysiological responsivity to corticotropin-releasing factor and stress. Brain Res. 722:1996;19-29.
113. Correa-Sales C., Rabin B.C., Maze M. A hypnotic response to dexmedetomidine, an alpha 2 agonist, is mediated in the locus coeruleus in rats. Anesthesiology. 76:1992;948-952.
114. Costa M.R., Casnellie J.E., Catterall W.A. Selective phosphorylation of the alpha subunit of the sodium channel by cAMP-dependent protein kinase. J. Biol. Chem. 257:1982;7918-7921.
115. Costa M.R., Catterall W.A. Cyclic AMP-dependent phosphorylation of the alpha subunit of the sodium channel in synaptic nerve ending particles. J. Biol. Chem. 259:1984;8210-8218.
116. Costa M.R., Catterall W.A. Phosphorylation of the alpha subunit of the sodium channel by protein kinase C. Cell Mol. Neurobiol. 4:1984;291-297.
117. Coull J.T., Middleton H.C., Robbins T.W., Sahakian B.J. Clonidine and diazepam have differential effects on tests of attention and learning. Psychopharmacology (Berl.). 120:1995;322-332.
118. Cummings S., Elde R., Ells J., Lindall A. Corticotropin-releasing factor immunoreactivity is widely distributed within the central nervous system of the rat: an immunohistochemical study. J. Neurosci. 3:1983;1355-1368.
119. Cunningham J.T., Nissen R., Renaud L.P. Norepinephrine injections in diagonal band of Broca selectively reduced the activity of vasopressin supraoptic neurons in the rat. Brain Res. 610:1993;152-155.
120. Cunningham K.A., Lakoski J.M. Electrophysiological effects of cocaine and procaine on dorsal raphe serotonin neurons. Eur. J. Pharmacol. 148:1988;457-462.
121. Cunningham K.A., Lakoski J.M. The interaction of cocaine with serotonin dorsal raphe neurons. Single-unit extracellular recording studies. Neuropsychopharmacology. 3:1990;41-50.
122. Curtis A.L., Drolet G., Valentino R.J. Hemodynamic stress activates locus coeruleus neurons of unanesthetized rats. Brain Res. Bull. 31:1993;737-744.
123. Curtis A.L., Lechner S.M., Pavcovich L.A., Valentino R.J. Activation of the locus coeruleus noradrenergic system by intracoerulear microinfusion of corticotropin-releasing factor: effects on discharge rate, cortical norepinephrine levels and cortical electroencephalographic activity. J. Pharmacol. Exp. Ther. 281:1997;163-172.
124. Curtis A.L., Pavcovich L.A., Grigoriadis D.E., Valentino R.J. Previous stress alters corticotropin-releasing factor neurotransmission in the locus coeruleus. Neuroscience. 65:1995;541-550.
125. Curtis A.L., Pavcovich L.A., Valentino R.J. Long-term regulation of locus ceruleus sensitivity to corticotropin-releasing factor by swim stress. J. Pharmacol. Exp. Ther. 289:1999;1211-1219.
126. Darracq L., Blanc G., Glowinski J., Tassin J.P. Importance of the noradrenaline-dopamine coupling in the locomotor activating effects of D-amphetamine. J. Neurosci. 18:1998;2729-2739.
127. De Sarro G.B., Ascioti C., Froio F., Libri V., Nistico G. Evidence that locus coeruleus is the site where clonidine and drugs acting at alpha 1- and alpha 2-adrenoceptors affect sleep and arousal mechanisms. Br. J. Pharmacol. 90:1987;675-685.
128. De Sarro G.B., Bagetta G., Ascioti C., Libri V., Nistico G. Microinfusion of clonidine and yohimbine into locus coeruleus alters EEG power spectrum: effects of aging and reversal by phosphatidylserine. Br. J. Pharmacol. 95:1988;1278-1286.
129. De Sarro G.B., Bagetta G., Ascioti C., Libri V., Nistico G. Effects of pertussis toxin on the behavioural and ECoG spectrum changes induced by clonidine and yohimbine after their microinfusion into the locus coeruleus. Br. J. Pharmacol. 96:1989;59-64.
130. Delfs J.M., Zhu Y., Druhan J.P., Aston-Jones G.S. Origin of noradrenergic afferents to the shell subregion of the nucleus accumbens: anterograde and retrograde tract-tracing studies in the rat. Brain Res. 806:1998;127-140.
131. Deutch A.Y. Prefrontal cortical dopamine systems and the elaboration of functional corticostriatal circuits: implications for schizophrenia and Parkinson's disease. J. Neural Transm. Gen. Sect. 91:1993;197-221.
132. Devauges V., Sara S.J. Activation of the noradrenergic system facilitates an attentional shift in the rat. Behav. Brain Res. 39:1990;19-28.
133. Devilbiss D.M., Waterhouse B.D. Tonic locus coeruleus output and signal transfer through somatosensory cortical circuits: I. Quiet resting. Soc. Neurosci. Abst. 25:1999;1121.
134. Devilbiss D.M., Waterhouse B.D. Norepinephrine exhibits two distinct profiles of action on sensory cortical neuron responses to excitatory synaptic stimuli. Synapse. 37:2000;273-282.
135. Diaz J., Ellison G., Masouka D. Stages of recovery from central norepinephrine lesions in enriched and impoverished environments: a behavioral and biochemical study. Exp. Brain Res. 31:1978;117-130.
136. Dickinson S.L., Gadie B., Tulloch I.F. Alpha 1- and alpha 2-adrenoreceptor antagonists differentially influence locomotor and stereotyped behaviour induced by d-amphetamine and apomorphine in the rat. Psychopharmacology (Berl.). 96:1988;521-527.
137. Dodt H.U., Pawelzik H., Zieglgansberger W. Actions of noradrenaline on neocortical neurons in vitro. Brain Res. 545:1991;307-311.
138. Dohlman H.G., Thorner J., Caron M.G., Lefkowitz R.J. Model systems for the study of seven-transmembrane-segment receptors. Annu. Rev. Biochem. 60:1991;653-688.
139. Domich L., Oakson G., Steriade M. Thalamic burst patterns in the naturally sleeping cat: a comparison between cortically projecting and reticularis neurones. J. Physiol. 379:1986;429-449.
140. Dragunow M., Currie R.W., Faull R.L., Robertson H.A., Jansen K. Immediate-early genes, kindling and long-term potentiation. Neurosci. Biobehav. Rev. 13:1989;301-313.
141. Drouin C., Darracq L., Trovero F., Blanc G., Glowinski J., Cotecchia S., Tassin J.P. Alpha1b-adrenergic receptors control locomotor and rewarding effects of psychostimulants and opiates. J. Neurosci. 22:2002;2873-2884.
142. Dunn A.J. Stress-related activation of cerebral dopaminergic systems. Ann. N.Y. Acad. Sci. 537:1988;188-205.
143. Dunn A.J., Berridge C.W. Corticotropin-releasing factor administration elicits a stress-like activation of cerebral catecholaminergic systems. Pharmacol. Biochem. Behav. 27:1987;685-691.
144. Dunn A.J., Berridge C.W. Physiological and behavioral responses to corticotropin-releasing factor administration: is CRF a mediator of anxiety or stress responses? Brain Res. Brain Res. Rev. 15:1990;71-100.
145. Dunn A.J., Kramarcy N.R. Neurochemical responses in stress: relationships between the hypothalamic-pituitary-adrenal and catecholamine systems. Iversen L.L., Iversen S.D., Snyder S.H. Handbook of Psychopharmacology. Vol. 18:1984;455-515 Plenum Publishing Corporation, New York.
146. Dutton A., Dyball R.E. Phasic firing enhances vasopressin release from the rat neurohypophysis. J. Physiol. 290:1979;433-440.
147. Einhorn L.C., Johansen P.A., White F.J. Electrophysiological effects of cocaine in the mesoaccumbens dopamine system: studies in the ventral tegmental area. J. Neurosci. 8:1988;100-112.
148. Ennis M., Aston-Jones G. Activation of locus coeruleus from nucleus paragigantocellularis: a new excitatory amino acid pathway in brain. J. Neurosci. 8:1988;3644-3657.
149. Ennis M., Aston-Jones G. GABA-mediated inhibition of locus coeruleus from the dorsomedial rostral medulla. J. Neurosci. 9:1989;2973-2981.
150. Ennis M., Aston-Jones G. Potent inhibitory input to locus coeruleus from the nucleus prepositus hypoglossi. Brain Res. Bull. 22:1989;793-803.
151. Erb S., Hitchcott P.K., Rajabi H., Mueller D., Shaham Y., Stewart J. Alpha-2 adrenergic receptor agonists block stress-induced reinstatement of cocaine seeking. Neuropsychopharmacology. 23:2000;138-150.
152. España R.A., Baldo B.A., Kelley A.E., Berridge C.W. Wake-promoting and sleep-suppressing actions of hypocretin (orexin): Basal forebrain sites of action. Neuroscience. 106:2001;699-715.
153. Evarts E.V. Effects of sleep and waking on spontaneous and evoked discharge of single units in visual cortex. Fed. Proc. 19:1960;828-837.
154. Fallon J.H., Koziell D.A., Moore R.Y. Catecholamine innervation of the basal forebrain. II. Amygdala, suprarhinal cortex and entorhinal cortex. J. Comp. Neurol. 180:1978;509-532.
155. Feenstra M.G. Dopamine and noradrenaline release in the prefrontal cortex in relation to unconditioned and conditioned stress and reward. Prog. Brain Res. 126:2000;133-163.
156. Feenstra M.G., Teske G., Botterblom M.H., de Bruin J.P. Dopamine and noradrenaline release in the prefrontal cortex of rats during classical aversive and appetitive conditioning to a contextual stimulus: interference by novelty effects. Neurosci. Lett. 272:1999;179-182.
157. Feenstra M.G., Vogel M., Botterblom M.H., Joosten R.N., de Bruin J.P. Dopamine and noradrenaline efflux in the rat prefrontal cortex after classical aversive conditioning to an auditory cue. Eur. J. Neurosci. 13:2001;1051-1054.
158. Ferry B., McGaugh J.L. Clenbuterol administration into the basolateral amygdala post-training enhances retention in an inhibitory avoidance task. Neurobiol. Learn. Mem. 72:1999;8-12.
159. Ferry B., Roozendaal B., McGaugh J.L. Basolateral amygdala noradrenergic influences on memory storage are mediated by an interaction between beta- and alpha1-adrenoceptors. J. Neurosci. 19:1999;5119-5123.
160. Ferry B., Roozendaal B., McGaugh J.L. Involvement of alpha1-adrenoceptors in the basolateral amygdala in modulation of memory storage. Eur. J. Pharmacol. 372:1999;9-16.
161. Ferry B., Roozendaal B., McGaugh J.L. Role of norepinephrine in mediating stress hormone regulation of long-term memory storage: a critical involvement of the amygdala. Biol. Psychiatry. 46:1999;1140-1152.
162. Findlay A.L., Hayward J.N. Spontaneous activity of single neurones in the hypothalamus of rabbits during sleep and waking. J. Physiol. 201:1969;237-258.
163. Finlay J.M., Zigmond M.J., Abercrombie E.D. Increased dopamine and norepinephrine release in medial prefrontal cortex induced by acute and chronic stress: effects of diazepam. Neuroscience. 64:1995;619-628.
164. Fischman M.W., Schuster C.R. Long-term behavioral changes in the rhesus monkey after multiple daily injections of d-methylamphetamine. J. Pharmacol. Exp. Ther. 201:1977;593-605.
165. Florin-Lechner S.M., Druhan J.P., Aston-Jones G., Valentino R.J. Enhanced norepinephrine release in prefrontal cortex with burst stimulation of the locus coeruleus. Brain Res. 742:1996;89-97.
166. Foehring R.C., Schwindt P.C., Crill W.E. Norepinephrine selectively reduces slow Ca2+- and Na+-mediated K+ currents in cat neocortical neurons. J. Neurophysiol. 61:1989;245-256.
167. Foote S.L., Aston-Jones G., Bloom F.E. Impulse activity of locus coeruleus neurons in awake rats and monkeys is a function of sensory stimulation and arousal. Proc. Natl. Acad. Sci. U.S.A. 77:1980;3033-3037.
168. Foote S.L., Aston-Jones G.S. Pharmacology and physiology of central noradrenergic systems. Bloom F.E., Kuroiwa T. Psychopharmacology: The Fourth Generation of Progress. 1995;335-345 Raven Press, Ltd, New York.
169. Foote S.L., Berridge C.W., Adams L.M., Pineda J.A. Electrophysiological evidence for the involvement of the locus coeruleus in alerting, orienting, and attending. Prog Brain Res. 88:1991;521-532.
170. Foote S.L., Bloom F.E., Aston-Jones G. Nucleus locus ceruleus: new evidence of anatomical and physiological specificity. Physiol. Rev. 63:1983;844-914.
171. Foote S.L., Freedman R., Oliver A.P. Effects of putative neurotransmitters on neuronal activity in monkey auditory cortex. Brain Res. 86:1975;229-242.
172. Foote S.L., Morrison J.H. Extrathalamic modulation of cortical function. Annu. Rev. Neurosci. 10:1987;67-95.
173. Fort P., Khateb A., Pegna A., Muhlethaler M., Jones B.E. Noradrenergic modulation of cholinergic nucleus basalis neurons demonstrated by in vitro pharmacological and immunohistochemical evidence in the guinea-pig brain. Eur. J. Neurosci. 7:1995;1502-1511.
174. Freedman R., Hoffer B.J., Woodward D.J., Puro D. Interaction of norepinephrine with cerebellar activity evoked by mossy and climbing fibers. Exp. Neurol. 55:1977;269-288.
175. Freud S. Uber coca. Byck R. Cocaine Papers. 1974;47-74 Stonehill Publishing, New York.
176. Fritschy J.M., Grzanna R. Restoration of ascending noradrenergic projections by residual locus coeruleus neurons: compensatory response to neurotoxin-induced cell death in the adult rat brain. J. Comp. Neurol. 321:1992;421-441.
177. Fung S.J., Barnes C.D. Evidence of facilitatory coerulospinal action in lumbar motoneurons of cats. Brain Res. 216:1981;299-311.
178. Fung S.J., Barnes C.D. Membrane excitability changes in hindlimb motoneurons induced by stimulation of the locus coeruleus in cats. Brain Res. 402:1987;230-242.
179. Fung S.J., Manzoni D., Chan J.Y., Pompeiano O., Barnes C.D. Locus coeruleus control of spinal motor output. Prog. Brain Res. 88:1991;395-409.
180. Gabriel S.M., Knott P.J., Haroutunian V. Alterations in cerebral cortical galanin concentrations following neurotransmitter-specific subcortical lesions in the rat. J. Neurosci. 15:1995;5526-5534.
181. Gatti P.J., Hill K.J., Da Silva A.M., Norman W.P., Gillis R.A. Central nervous system site of action for the hypotensive effect of clonidine in the cat. J. Pharmacol. Exp. Ther. 245:1988;373-380.
182. George M.J. Modification of receptive fields of posteriomedial barrel subfield neocortical single units by known concentrations of iontophoresed noradrenaline in the rat. Int. J. Neurosci. 65:1992;69-81.
183. Gold M.S. Cocaine (and crack): clinical aspects. Lowinson J.H., Ruiz P.R., Millman R.B., Langrod J.G. Substance Abuse: A Comprehensive Textbook. 1992;205-221 Williams and Wilkins, Baltimore.
184. Gold M.S. Cocaine (and crack): neurobiology. Lowinson J.H., Ruiz P.R., Millman R.B., Langrod J.G. Substance Abuse: A Comprehensive Textbook. 1992;222-235 Wilkins and Wilkins, Baltimore.
185. Gold M.S. Opiate addiction and the locus coeruleus. The clinical utility of clonidine, naltrexone, methadone, and buprenorphine. Psychiatr. Clin. North Am. 16:1993;61-73.
186. Gold P.E. Role of glucose in regulating the brain and cognition. Am. J. Clin. Nutr. 61:1995;987S-995S.
187. Gold P.E., van Buskirk R.B., McGaugh J.L. Effects of hormones on time-dependent memory storage processes. Prog. Brain Res. 42:1975;210-211.
188. Goldman-Rakic P.S., Brown R.M. Regional changes of monoamines in cerebral cortex and subcortical structures of aging rhesus monkeys. Neuroscience. 6:1981;177-187.
189. Goldman-Rakic P.S., Lidow M.S., Gallager D.W. Overlap of dopaminergic, adrenergic, and serotoninergic receptors and complementarity of their subtypes in primate prefrontal cortex. J. Neurosci. 10:1990;2125-2138.
190. Grant S.J., Redmond D.E. Jr. Neuronal activity of the locus ceruleus in awake Macaca arctoides. Exp. Neurol. 84:1984;701-708.
191. Greengard P., Jen J., Nairn A.C., Stevens C.F. Enhancement of the glutamate response by cAMP-dependent protein kinase in hippocampal neurons. Science. 253:1991;1135-1138.
192. Greenhill L.L. Clinical effects of stimulant medication in ADHD. Solanto M.V., Arnsten A.F.T., Castellanos F.X. Stimulant Drugs and ADHD: Basic and Clinical Neuroscience. 2001;31-71 Oxford University Press, New York.
193. Grzanna R., Fritschy J.M. Efferent projections of different subpopulations of central noradrenaline neurons. Prog. Brain Res. 88:1991;89-101.
194. Grzanna R., Molliver M.E. The locus coeruleus in the rat: an immunohistochemical delineation. Neuroscience. 5:1980;21-40.
195. Gubits R.M., Smith T.M., Fairhurst J.L., Yu H. Adrenergic receptors mediate changes in c-fos mRNA levels in brain. Brain Res. Mol. Brain Res. 6:1989;39-45.
196. Guitart X., Nestler E.J. Second messenger and protein phosphorylation mechanisms underlying opiate addiction: studies in the rat locus coeruleus. Neurochem. Res. 18:1993;5-13.
197. Guzowski J.F., Lyford G.L., Stevenson G.D., Houston F.P., McGaugh J.L., Worley P.F., Barnes C.A. Inhibition of activity-dependent arc protein expression in the rat hippocampus impairs the maintenance of long-term potentiation and the consolidation of long-term memory. J. Neurosci. 20:2000;3993-4001.
198. Guzowski J.F., Setlow B., Wagner E.K., McGaugh J.L. Experience-dependent gene expression in the rat hippocampus after spatial learning: a comparison of the immediate-early genes Arc, c-fos, and zif268. J. Neurosci. 21:2001;5089-5098.
199. Hagan J.J., Leslie R.A., Patel S., Evans M.L., Wattam T.A., Holmes S., Benham C.D., Taylor S.G., Routledge C., Hemmati P., Munton R.P., Ashmeade T.E., Shah A.S., Hatcher J.P., Hatcher P.D., Jones D.N., Smith M.I., Piper D.C., Hunter A.J., Porter R.A., Upton N. Orexin A activates locus coeruleus cell firing and increases arousal in the rat. Proc. Natl. Acad. Sci. U.S.A. 96:1999;10911-10916.
200. Hallman H., Jonsson G. Pharmacological modifications of the neurotoxic action of the noradrenaline neurotoxin DSP4 on central noradrenaline neurons. Eur. J. Pharmacol. 103:1984;269-278.
201. Harik S.I., Duckrow R.B., LaManna J.C., Rosenthal M., Sharma V.K., Banerjee S.P. Cerebral compensation for chronic noradrenergic denervation induced by locus ceruleus lesion: recovery of receptor binding, isoproterenol-induced adenylate cyclase activity, and oxidative metabolism. J. Neurosci. 1:1981;641-649.
202. Harley C. Noradrenergic and locus coeruleus modulation of the perforant path-evoked potential in rat dentate gyrus supports a role for the locus coeruleus in attentional and memorial processes. Prog. Brain Res. 88:1991;307-321.
203. Harley C.W., Sara S.J. Locus coeruleus bursts induced by glutamate trigger delayed perforant path spike amplitude potentiation in the dentate gyrus. Exp. Brain Res. 89:1992;581-587.
204. Haroutunian V., Kanof P.D., Tsuboyama G., Davis K.L. Restoration of cholinomimetic activity by clonidine in cholinergic plus noradrenergic lesioned rats. Brain Res. 507:1990;261-266.
205. Harris G.C., Hausken Z.E., Williams J.T. Cocaine induced synchronous oscillations in central noradrenergic neurons in vitro. Neuroscience. 50:1992;253-257.
206. Harris G.C., Williams J.T. Sensitization of locus ceruleus neurons during withdrawal from chronic stimulants and antidepressants. J. Pharmacol. Exp. Ther. 261:1992;476-483.
207. Harrison N.L., Lambert N.A. Modification of GABAA receptor function by an analog of cyclic AMP. Neurosci. Lett. 105:1989;137-142.
208. Hartmann E. Drugs against insomnia. Internist (Berl.). 19:1978;552-556.
209. Hatfield T., McGaugh J.L. Norepinephrine infused into the basolateral amygdala posttraining enhances retention in a spatial water maze task. Neurobiol. Learn. Mem. 71:1999;232-239.
210. Heginbotham L.R., Dunwiddie T.V. Long-term increases in the evoked population spike in the CA1 region of rat hippocampus induced by beta-adrenergic receptor activation. J. Neurosci. 11:1991;2519-2527.
211. P.R. Hernandez, I.G. Chavez, Sleep induced by electrical or chemical stimulation of the forebrain, Electroencephalogr. Clin. Neurophysiol. (1963) Suppl.
212. Hobson J.A., McCarley R.W., Wyzinski P.W. Sleep cycle oscillation: reciprocal discharge by two brainstem neuronal groups. Science. 189:1975;55-58.
213. Hof P.R., Pascale E., Magistretti P.J. K+ at concentrations reached in the extracellular space during neuronal activity promotes a Ca2+-dependent glycogen hydrolysis in mouse cerebral cortex. J. Neurosci. 8:1988;1922-1928.
214. Hoffer B.J., Siggins G.R., Bloom F.E. Studies on norepinephrine-containing afferents to Purkinje cells of rat cerebellum. II. Sensitivity of Purkinje cells to norepinephrine and related substances administered by microiontophoresis. Brain Res. 25:1971;523-534.
215. Hoffer B.J., Siggins G.R., Oliver A.P., Bloom F.E. Activation of the pathway from locus coeruleus to rat cerebellar Purkinje neurons: pharmacological evidence of noradrenergic central inhibition. J. Pharmacol. Exp. Ther. 184:1973;553-569.
216. Holets V.R., Hokfelt T., Rokaeus A., Terenius L., Goldstein M. Locus coeruleus neurons in the rat containing neuropeptide Y, tyrosine hydroxylase or galanin and their efferent projections to the spinal cord, cerebral cortex and hypothalamus. Neuroscience. 24:1988;893-906.
217. Holstege J.C., Kuypers H.G. Brainstem projections to lumbar motoneurons in rat - I. An ultrastructural study using autoradiography and the combination of autoradiography and horseradish peroxidase histochemistry. Neuroscience. 21:1987;345-367.
218. Hopkins W.F., Johnston D. Frequency-dependent noradrenergic modulation of long-term potentiation in the hippocampus. Science. 226:1984;350-352.
219. Hopkins W.F., Johnston D. Noradrenergic enhancement of long-term potentiation at mossy fiber synapses in the hippocampus. J. Neurophysiol. 59:1988;667-687.
220. Horrigan J.P., Barnhill L.J. Guanfacine for treatment of attention-deficit-hyperactivity disorder in boys. J. Am. Acad. Child Adolesc. Psychiatry. 34:1995;215-223.
221. Horvath T.L., Peyron C., Diano S., Ivanov A., Aston-Jones G., Kilduff T.S., van Den Pol A.N. Hypocretin (orexin) activation and synaptic innervation of the locus coeruleus noradrenergic system. J. Comp. Neurol. 415:1999;145-159.
222. Hunt R.D., Arnsten A.F., Asbell M.D. An open trial of guanfacine in the treatment of attention-deficit hyperactivity disorder. J. Am. Acad. Child Adolesc. Psychiatry. 34:1995;50-54.
223. Hunt R.D., Minderaa R.B., Cohen D.J. Clonidine benefits children with attention deficit disorder and hyperactivity: report of a double-blind placebo-crossover therapeutic trial. J. Am. Acad. Child Psychiatry. 24:1985;617-629.
224. Hyvarinen J., Poranen A., Jokinen Y. Influence of attentive behavior on neuronal responses to vibration in primary somatosensory cortex of the monkey. J. Neurophysiol. 43:1980;870-882.
225. Ibrahim M.Z. Glycogen and its related enzymes of metabolism in the central nervous system. Adv. Anat. Embryol. Cell Biol. 52:1975;3-89.
226. Ino T., Itoh K., Kamiya H., Shigemoto R., Akiguchi I., Mizuno N. Direct projections of non-pyramidal neurons of Ammon's horn to the supramammillary region in the cat. Brain Res. 460:1988;173-177.
227. Introini-Collison I.B., McGaugh J.L. Epinephrine modulates long-term retention of an aversively motivated discrimination. Behav. Neural Biol. 45:1986;358-365.
228. Introini-Collison I.B., Nagahara A.H., McGaugh J.L. Memory enhancement with intra-amygdala post-training naloxone is blocked by concurrent administration of propranolol. Brain Res. 476:1989;94-101.
229. Ishimatsu M., Williams J.T. Synchronous activity in locus coeruleus results from dendritic interactions in pericoerulear regions. J. Neurosci. 16:1996;5196-5204.
230. Ivanov A., Aston-Jones G. Local opiate withdrawal in locus coeruleus neurons in vitro. J. Neurophysiol. 85:2001;2388-2397.
231. Ivanova S., Rajkowski J., Silakov V., Watanabe T., Aston-Jones G. Local chemomanipulatikons of locus coeruleus (LC) activity in monkeys alter cortical event-related potentials (ERPs) and task performance. Neurosci. Abst. 23:1997;1587.
232. Jackson W.J., Buccafusco J.J. Clonidine enhances delayed matching-to-sample performance by young and aged monkeys. Pharmacol. Biochem. Behav. 39:1991;79-84.
233. Jiang M., Griff E.R., Ennis M., Zimmer L.A., Shipley M.T. Activation of locus coeruleus enhances the responses of olfactory bulb mitral cells to weak olfactory nerve input. J. Neurosci. 16:1996;6319-6329.
234. Jimenez-Rivera C.A., Waterhouse B.D. Effects of systemically and locally applied cocaine on cerebrocortical neuron responsiveness to afferent synaptic inputs and glutamate. Brain Res. 546:1991;287-296.
235. Jodo E., Chiang C., Aston-Jones G. Potent excitatory influence of prefrontal cortex activity on noradrenergic locus coeruleus neurons. Neuroscience. 83:1998;63-79.
236. Johanson C.E., Fischman M.W. The pharmacology of cocaine related to its abuse. Pharmacol. Rev. 41:1989;3-52.
237. Jones B.E., Harper S.T., Halaris A.E. Effects of locus coeruleus lesions upon cerebral monoamine content, sleep-wakefulness states and the response to amphetamine in the cat. Brain Res. 124:1977;473-496.
238. Jones B.E., Moore R.Y. Catecholamine-containing neurons of the nucleus locus coeruleus in the cat. J. Comp. Neurol. 157:1974;43-51.
239. Jones C.R., Palacios J.M. Autoradiography of adrenoceptors in rat and human brain: alpha-adrenoceptor and idazoxan binding sites. Prog. Brain Res. 88:1991;271-291.
240. Jones R.S., Olpe H.R. Activation of the noradrenergic projection from locus coeruleus reduces the excitatory responses of anterior cingulate cortical neurones to substance P. Neuroscience. 13:1984;819-825.
241. Jung T.P., Makeig S., Stensmo M., Sejnowski T.J. Estimating alertness from the EEG power spectrum. IEEE Trans. Biomed. Eng. 44:1997;60-69.
242. Kahnemann D. Attention and Effort. 1973;Prentice-Hall, Englewood Cliffs, NJ.
243. Kalia M., Sullivan J.M. Brainstem projections of sensory and motor components of the vagus nerve in the rat. J. Comp. Neurol. 211:1982;248-265.
244. Karelson E., Laasik J., Sillard R. Regulation of adenylate cyclase by galanin, neuropeptide Y, secretin and vasoactive intestinal polypeptide in rat frontal cortex, hippocampus and hypothalamus. Neuropeptides. 28:1995;21-28.
245. Karnovsky M.L., Reich P., Anchors J.M., Burrows B.L. Changes in brain glycogen during slow-wave sleep in the rat. J. Neurochem. 41:1983;1498-1501.
246. Kasamatsu T., Heggelund P. Single cell responses in cat visual cortex to visual stimulation during iontophoresis of noradrenaline. Exp. Brain Res. 45:1982;317-327.
247. Kaukinen S., Pyykko K. The potentiation of halothane anaesthesia by clonidine. Acta Anaesthesiol. Scand. 23:1979;107-111.
248. Kayama Y., Negi T., Sugitani M., Iwama K. Effects of locus coeruleus stimulation on neuronal activities of dorsal lateral geniculate nucleus and perigeniculate reticular nucleus of the rat. Neuroscience. 7:1982;655-666.
249. Kety S.S. The possible role of the adrenergic systems of the cortex in learning. Res. Publ. Assoc. Res. Nerv. Ment. Dis. 50:1972;376-389.
250. Kilduff T.S., Peyron C. The hypocretin/orexin ligand-receptor system: implications for sleep and sleep disorders. Trends Neurosci. 23:2000;359-365.
251. Kinney G.A., Emmerson P.J., Miller R.J. Galanin receptor-mediated inhibition of glutamate release in the arcuate nucleus of the hypothalamus. J. Neurosci. 18:1998;3489-3500.
252. Kirkness E.F., Bovenkerk C.F., Ueda T., Turner A.J. Phosphorylation of gamma-aminobutyrate (GABA)/benzodiazepine receptors by cyclic AMP-dependent protein kinase. Biochem. J. 259:1989;613-616.
253. Kirkwood A., Rozas C., Kirkwood J., Perez F., Bear M.F. Modulation of long-term synaptic depression in visual cortex by acetylcholine and norepinephrine. J. Neurosci. 19:1999;1599-1609.
254. Kitchigina V., Vankov A., Harley C., Sara S.J. Novelty-elicited, noradrenaline-dependent enhancement of excitability in the dentate gyrus. Eur. J. Neurosci. 9:1997;41-47.
255. Knight R.T., Hillyard S.A., Woods D.L., Neville H.J. The effects of frontal cortex lesions on event-related potentials during auditory selective attention. Electroencephalogr. Clin. Neurophysiol. 52:1981;571-582.
256. Kogan J.H., Nestler E.J., Aghajanian G.K. Elevated basal firing rates and enhanced responses to 8-Br-cAMP in locus coeruleus neurons in brain slices from opiate-dependent rats. Eur. J. Pharmacol. 211:1992;47-53.
257. Koob G.F., Bloom F.E. Corticotropin-releasing factor and behavior. Fed. Proc. 44:1985;259-263.
258. Korf J., Aghajanian G.K., Roth R.H. Increased turnover of norepinephrine in the rat cerebral cortex during stress: role of the locus coeruleus. Neuropharmacology. 12:1973;933-938.
259. Kossl M., Vater M. Noradrenaline enhances temporal auditory contrast and neuronal timing precision in the cochlear nucleus of the mustached bat. J. Neurosci. 9:1989;4169-4178.
260. Kramarcy N.R., Delanoy R.L., Dunn A.J. Footshock treatment activates catecholamine synthesis in slices of mouse brain regions. Brain Res. 290:1984;311-319.
261. Kuczenski R., Segal D.S. Neurochemistry of amphetamine. Cho A.K., Segal D.S. Amphetamine and Its Analogues: Psychopharmacology, Toxicology and Abuse. 1994;81-113 Academic Press, San Diego.
262. Kuczenski R., Segal D.S. Effects of methylphenidate on extracellular dopamine, serotonin, and norepinephrine: comparison with amphetamine. J. Neurochem. 68:1997;2032-2037.
263. Kuczenski R., Segal D.S. Locomotor effects of acute and repeated threshold doses of amphetamine and methylphenidate: relative roles of dopamine and norepinephrine. J. Pharmacol. Exp. Ther. 296:2001;876-883.
264. Kuczenski R., Segal D.S. Exposure of adolescent rats to oral methylphenidate: preferential effects on extracellular norepinephrine and absence of sensitization and cross-sensitization to methamphetamine. J. Neurosci. 22:2002;7264-7271.
265. Kuczenski R., Segal D.S., Cho A.K., Melega W. Hippocampus norepinephrine, caudate dopamine and serotonin, and behavioral responses to the stereoisomers of amphetamine and methamphetamine. J. Neurosci. 15:1995;1308-1317.
266. Kumar V.M., Datta S., Chhina G.S., Singh B. Alpha adrenergic system in medial preoptic area involved in sleep-wakefulness in rats. Brain Res. Bull. 16:1986;463-468.
267. Kumar V.M., Sharma R., Wadhwa S., Manchanda S.K. Sleep-inducing function of noradrenergic fibers in the medial preoptic area. Brain Res. Bull. 32:1993;153-158.
268. Kwiat G.C., Basbaum A.I. The origin of brainstem noradrenergic and serotonergic projections to the spinal cord dorsal horn in the rat. Somatosens. Mot. Res. 9:1992;157-173.
269. Lal H., Chessick R.D. Lethal effects of aggregation and electric shock in mice treated with cocaine. Nature. 208:1965;295-296.
270. Larkman A., Mason A. Correlations between morphology and electrophysiology of pyramidal neurons in slices of rat visual cortex. I. Establishment of cell classes. J. Neurosci. 10:1990;1407-1414.
271. Lavicky J., Dunn A.J. Corticotropin-releasing factor stimulates catecholamine release in hypothalamus and prefrontal cortex in freely moving rats as assessed by microdialysis. J. Neurochem. 60:1993;602-612.
272. Lechner J., Leah J.D., Zimmerman M. Brainstem peptidergic neurons projecting to the medial and lateral thalamus and zona incerta in the rat. Brain Res. 603:1993;47-56.
273. Lechner S.M., Curtis A.L., Brons R., Valentino R.J. Locus coeruleus activation by colon distention: role of corticotropin-releasing factor and excitatory amino acids. Brain Res. 756:1997;114-124.
274. Lee M.K., Graham S.N., Gold P.E. Memory enhancement with posttraining intraventricular glucose injections in rats. Behav. Neurosci. 102:1988;591-595.
275. Lennartz R.C., Hellems K.L., Mook E.R., Gold P.E. Inhibitory avoidance impairments induced by intra-amygdala propranolol are reversed by glutamate but not glucose. Behav. Neurosci. 110:1996;1033-1039.
276. Leri F., Flores J., Rodaros D., Stewart J. Blockade of stress-induced but not cocaine-induced reinstatement by infusion of noradrenergic antagonists into the bed nucleus of the stria terminalis or the central nucleus of the amygdala. J. Neurosci. 22:2002;5713-5718.
277. Leslie F.M., Loughlin S.E., Sternberg D.B., McGaugh J.L., Young L.E., Zornetzer S.F. Noradrenergic changes and memory loss in aged mice. Brain Res. 359:1985;292-299.
278. Levitt P., Moore R.Y. Noradrenaline neuron innervation of the neocortex in the rat. Brain Res. 139:1978;219-231.
279. Levitt P., Moore R.Y. Development of the noradrenergic innervation of neocortex. Brain Res. 162:1979;243-259.
280. Lewis D.A. The catecholamine innervation of primate cerebral cortex. Solanto M.V., Arnsten A.F.T., Castellanos F.X. Stimulant Drugs and ADHD: Basic and Clinical Neuroscience. 2001;77-103 Oxford University Press, New York.
281. Lewis B.L., O'Donnell P. Ventral tegmental area afferents to the prefrontal cortex maintain membrane potential 'up' states in pyramidal neurons via D(1) dopamine receptors. Cereb. Cortex. 10:2000;1168-1175.
282. Lewis D.A., Campbell M.J., Foote S.L., Goldstein M., Morrison J.H. The distribution of tyrosine hydroxylase-immunoreactive fibers in primate neocortex is widespread but regionally specific. J. Neurosci. 7:1987;279-290.
283. Li B.M., Mao Z.M., Wang M., Mei Z.T. Alpha-2 adrenergic modulation of prefrontal cortical neuronal activity related to spatial working memory in monkeys. Neuropsychopharmacology. 21:1999;601-610.
284. Li B.M., Mei Z.T. Delayed-response deficit induced by local injection of the alpha 2-adrenergic antagonist yohimbine into the dorsolateral prefrontal cortex in young adult monkeys. Behav. Neural Biol. 62:1994;134-139.
285. Li M., West J.W., Numann R., Murphy B.J., Scheuer T., Catterall W.A. Convergent regulation of sodium channels by protein kinase C and cAMP-dependent protein kinase. Science. 261:1993;1439-1442.
286. Liang K.C., Bennett C., McGaugh J.L. Peripheral epinephrine modulates the effects of post-training amygdala stimulation on memory. Behav. Brain Res. 15:1985;93-100.
287. Liang K.C., Juler R.G., McGaugh J.L. Modulating effects of posttraining epinephrine on memory: involvement of the amygdala noradrenergic system. Brain Res. 368:1986;125-133.
288. Lidbrink P. The effect of lesions of ascending noradrenaline pathways on sleep and waking in the rat. Brain Res. 74:1974;19-40.
289. Lidov H.G., Molliver M.E., Zecevic N.R. Characterization of the monoaminergic innervation of immature rat neocortex: a histofluorescence analysis. J. Comp. Neurol. 181:1978;663-679.
290. Lin L., Faraco J., Li R., Kadotani H., Rogers W., Lin X., Qiu X., de Jong P.J., Nishino S., Mignot E. The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene [see comments]. Cell. 98:1999;365-376.
291. Lindvall O., Bjorklund A. The organization of the ascending catecholamine neuron systems in the rat brain as revealed by the glyoxylic acid fluorescence method. Acta Physiol. Scand. Suppl. 412:1974;1-48.
292. Livingstone M.S., Hubel D.H. Effects of sleep and arousal on the processing of visual information in the cat. Nature. 291:1981;554-561.
293. Llinas R.R. The intrinsic electrophysiological properties of mammalian neurons: insights into central nervous system function. Science. 242:1988;1654-1664.
294. Logue M.P., Growdon J.H., Coviella I.L., Wurtman R.J. Differential effects of DSP-4 administration on regional brain norepinephrine turnover in rats. Life Sci. 37:1985;403-409.
295. Lorden J.F., Callahan M., Dawson R. Jr. Depletion of central catecholamines alters amphetamine- and fenfluramine-induced taste aversions in the rat. J. Comp. Physiol. Psychol. 94:1980;99-114.
296. Loughlin S.E., Foote S.L., Fallon J.H. Locus coeruleus projections to cortex: topography, morphology and collateralization. Brain Res. Bull. 9:1982;287-294.
297. Loughlin S.E., Foote S.L., Grzanna R. Efferent projections of nucleus locus coeruleus: morphologic subpopulations have different efferent targets. Neuroscience. 18:1986;307-319.
298. Mackworth J.F. Vigilance and Attention. 1970;Penguin, Baltimore.
299. Madison D.V., Nicoll R.A. Actions of noradrenaline recorded intracellularly in rat hippocampal CA1 pyramidal neurones, in vitro. J. Physiol. 372:1986;221-244.
300. Magistretti P.J. Regulation of energy metabolism in the cerebral cortex by VIP (vasoactive intestinal peptide) neurons: an example of peptidergic neural transmission. Neurochirurgie. 32:1986;324-331.
301. Magistretti P.J. Intercellular communication mediated by VIP in the cerebral cortex. Peptides. 7:(Suppl. 1):1986;169-173.
302. Magistretti P.J., Morrison J.H. Noradrenaline- and vasoactive intestinal peptide-containing neuronal systems in neocortex: functional convergence with contrasting morphology. Neuroscience. 24:1988;367-378.
303. Magistretti P.J., Morrison J.H., Shoemaker W.J., Sapin V., Bloom F.E. Vasoactive intestinal polypeptide induces glycogenolysis in mouse cortical slices: a possible regulatory mechanism for the local control of energy metabolism. Proc. Natl. Acad. Sci. U.S.A. 78:1981;6535-6539.
304. Magistretti P.J., Schorderet M. VIP and noradrenaline act synergistically to increase cyclic AMP in cerebral cortex. Nature. 308:1984;280-282.
305. Makeig S., Inlow M. Lapses in alertness: coherence of fluctuations in performance and EEG spectrum. Electroencephalogr. Clin. Neurophysiol. 86:1993;23-35.
306. Makeig S., Jung T.P. Tonic, phasic, and transient EEG correlates of auditory awareness in drowsiness. Brain Res. Cogn. Brain Res. 4:1996;15-25.
307. Maldonado R. Participation of noradrenergic pathways in the expression of opiate withdrawal: biochemical and pharmacological evidence. Neurosci. Biobehav. Rev. 21:1997;91-104.
308. Mallick B.N., Alam M.N. Different types of norepinephrinergic receptors are involved in preoptic area mediated independent modulation of sleep-wakefulness and body temperature. Brain Res. 591:1992;8-19.
309. Manley L.D., Kuczenski R., Segal D.S., Young S.J., Groves P.M. Effects of frequency and pattern of medial forebrain bundle stimulation on caudate dialysate dopamine and serotonin. J. Neurochem. 58:1992;1491-1498.
310. Manunta Y., Edeline J.M. Effects of noradrenaline on frequency tuning of rat auditory cortex neurons. Eur. J. Neurosci. 9:1997;833-847.
311. Mao Z.M., Arnsten A.F., Li B.M. Local infusion of an alpha-1 adrenergic agonist into the prefrontal cortex impairs spatial working memory performance in monkeys. Biol. Psychiatry. 46:1999;1259-1265.
312. Marrocco R.T., Lane R.F., McClurkin J.W., Blaha C.D., Alkire M.F. Release of cortical catecholamines by visual stimulation requires activity in thalamocortical afferents of monkey and cat. J. Neurosci. 7:1987;2756-2767.
313. Marson L. Identification of central nervous system neurons that innervate the bladder body, bladder base, or external urethral sphincter of female rats: a transneuronal tracing study using pseudorabies virus. J. Comp. Neurol. 389:1997;584-602.
314. Marwaha J., Aghajanian G.K. Relative potencies of alpha-1 and alpha-2 antagonists in the locus ceruleus, dorsal raphe and dorsal lateral geniculate nuclei: an electrophysiological study. J. Pharmacol. Exp. Ther. 222:1982;287-293.
315. Mason A., Larkman A. Correlations between morphology and electrophysiology of pyramidal neurons in slices of rat visual cortex. II. Electrophysiology. J. Neurosci. 10:1990;1415-1428.
316. Mason S.T., Fibiger H.C. Regional topography within noradrenergic locus coeruleus as revealed by retrograde transport of horseradish peroxidase. J. Comp. Neurol. 187:1979;703-724.
317. McCarley R.W., Benoit O., Barrionuevo G. Lateral geniculate nucleus unitary discharge in sleep and waking: state- and rate-specific aspects. J. Neurophysiol. 50:1983;798-818.
318. McCormick D.A. Cholinergic and noradrenergic modulation of thalamocortical processing. Trends Neurosci. 12:1989;215-221.
319. McCormick D.A., Bal T. Sleep and arousal: thalamocortical mechanisms. Annu. Rev. Neurosci. 20:1997;185-215.
320. McCormick D.A., Connors B.W., Lighthall J.W., Prince D.A. Comparative electrophysiology of pyramidal and sparsely spiny stellate neurons of the neocortex. J. Neurophysiol. 54:1985;782-806.
321. McCormick D.A., Feeser H.R. Functional implications of burst firing and single spike activity in lateral geniculate relay neurons. Neuroscience. 39:1990;103-113.
322. McCormick D.A., Pape H.C. Noradrenergic and serotonergic modulation of a hyperpolarization-activated cation current in thalamic relay neurones. J. Physiol. 431:1990;319-342.
323. McCormick D.A., Pape H.C., Williamson A. Actions of norepinephrine in the cerebral cortex and thalamus: implications for function of the central noradrenergic system. Prog. Brain Res. 88:1991;293-305.
324. McCormick D.A., Prince D.A. Two types of muscarinic response to acetylcholine in mammalian cortical neurons. Proc. Natl. Acad. Sci. U.S.A. 82:1985;6344-6348.
325. McCormick D.A., Prince D.A. Acetylcholine induces burst firing in thalamic reticular neurones by activating a potassium conductance. Nature. 319:1986;402-405.
326. McCormick D.A., Prince D.A. Noradrenergic modulation of firing pattern in guinea pig and cat thalamic neurons, in vitro. J. Neurophysiol. 59:1988;978-996.
327. McCune S.K., Voigt M.M., Hill J.M. Expression of multiple alpha adrenergic receptor subtype messenger RNAs in the adult rat brain. Neuroscience. 57:1993;143-151.
328. McGaugh J.L. Memory - a century of consolidation. Science. 287:2000;248-251.
329. McGaugh J.L., Cahill L., Roozendaal B. Involvement of the amygdala in memory storage: interaction with other brain systems. Proc. Natl. Acad. Sci. U.S.A. 93:1996;13508-13514.
330. McGinty D.J., Sterman M.B. Sleep suppression after basal forebrain lesions in the cat. Science. 160:1968;1253-1255.
331. McLean J., Waterhouse B.D. Noradrenergic modulation of cat area 17 neuronal responses to moving visual stimuli. Brain Res. 667:1994;83-97.
332. McNay E.C., Gold P.E. Memory modulation across neural systems: intra-amygdala glucose reverses deficits caused by intraseptal morphine on a spatial task but not on an aversive task. J. Neurosci. 18:1998;3853-3858.
333. Mehta M.A., Sahakian B.J., Robbins T.W. Comparative psycholpharmacology of methylphenidate and related drugs in human volunteers, patients with ADHD, and experimental animals. Solanto M.V., Arnsten A.F.T., Castellanos F.X. Stimulant Drugs and ADHD: Basic and Clinical Neuroscience. 2001;303-331 Oxford University Press, New York.
334. Meibach R.C., Siegel A. Efferent connections of the septal area in the rat: an analysis utilizing retrograde and anterograde transport methods. Brain Res. 119:1977;1-20.
335. Melander T., Hokfelt T., Rokaeus A. Distribution of galaninlike immunoreactivity in the rat central nervous system. J. Comp. Neurol. 248:1986;475-517.
336. Melia K.R., Duman R.S. Involvement of corticotropin-releasing factor in chronic stress regulation of the brain noradrenergic system. Proc. Natl. Acad. Sci. U.S.A. 88:1991;8382-8386.
337. Merchenthaler I., Lopez F.J., Lennard D.E., Negro-Vilar A. Sexual differences in the distribution of neurons coexpressing galanin and luteinizing hormone-releasing hormone in the rat brain. Endocrinology. 129:1991;1977-1986.
338. Merchenthaler I., Vigh S., Petrusz P., Schally A.V. Immunocytochemical localization of corticotropin-releasing factor (CRF) in the rat brain. Am. J. Anat. 165:1982;385-396.
339. Metherate R., Cox C.L., Ashe J.H. Cellular bases of neocortical activation: modulation of neural oscillations by the nucleus basalis and endogenous acetylcholine. J. Neurosci. 12:1992;4701-4711.
340. Mignot E. A commentary on the neurobiology of the hypocretin/orexin system. Neuropsychopharmacology. 25:2001;S5-13.
341. Milbrandt J. A nerve growth factor-induced gene encodes a possible transcriptional regulatory factor. Science. 238:1987;797-799.
342. Mogilnicka E. Increase in beta- and alpha 1-adrenoceptor binding sites in the rat brain and in the alpha 1-adrenoceptor functional sensitivity after the DSP-4-induced noradrenergic denervation. Pharmacol. Biochem. Behav. 25:1986;743-746.
343. Moises H.C., Waterhouse B.D., Woodward D.J. Locus coeruleus stimulation potentiates Purkinje cell responses to afferent input: the climbing fiber system. Brain Res. 222:1981;43-64.
344. Moises H.C., Waterhouse B.D., Woodward D.J. Locus coeruleus stimulation potentiates local inhibitory processes in rat cerebellum. Brain Res. Bull. 10:1983;795-804.
345. Moises H.C., Woodward D.J. Potentiation of GABA inhibitory action in cerebrllum by locus coeruleus stimulation. Brain Res. 182:1980;327-344.
346. Moises H.C., Woodward D.J., Hoffer B.J., Freedman R. Interactions of norepinephrine with Purkinje cell responses to putative amino acid neurotransmitters applied by microiontophoresis. Exp. Neurol. 64:1979;493-515.
347. Monnikes H., Schmidt B.G., Tebbe J., Bauer C., Tache Y. Microinfusion of corticotropin releasing factor into the locus coeruleus/subcoeruleus nuclei stimulates colonic motor function in rats. Brain Res. 644:1994;101-108.
348. Monnikes H., Tebbe J., Bauer C., Lauer G., Arnold R. Microinfusion of corticotropin-releasing factor into the locus coeruleus/subcoeruleus nuclei inhibits gastric acid secretion via spinal pathways in the rat. Brain Res. 728:1996;157-165.
349. Mooney R.D., Bennett-Clarke C., Chiaia N.L., Sahibzada N., Rhoades R.W. Organization and actions of the noradrenergic input to the hamster's superior colliculus. J. Comp. Neurol. 292:1990;214-230.
350. Moore R.Y., Bloom F.E. Central catecholamine neuron systems: anatomy and physiology of the norepinephrine and epinephrine systems. Annu. Rev. Neurosci. 2:1979;113-168.
351. Moore R.Y., Gustafson E.L. The distribution of dopamine-beta-hydroxylase, neuropeptide Y and galanin in locus coeruleus neurons. J. Chem. Neuroanat. 2:1989;95-106.
352. Morrison J.H., Foote S.L. Noradrenergic and serotoninergic innervation of cortical, thalamic, and tectal visual structures in Old and New World monkeys. J. Comp. Neurol. 243:1986;117-138.
353. Morrison J.H., Grzanna R., Molliver M.E., Coyle J.T. The distribution and orientation of noradrenergic fibers in neocortex of the rat: an immunofluorescence study. J. Comp. Neurol. 181:1978;17-39.
354. Morrison J.H., Magistretti P.J., Benoit R., Bloom F.E. The distribution and morphological characteristics of the intracortical VIP-positive cell: an immunohistochemical analysis. Brain Res. 292:1984;269-282.
355. Moss S.J., Smart T.G., Blackstone C.D., Huganir R.L. Functional modulation of GABAA receptors by cAMP-dependent protein phosphorylation. Science. 257:1992;661-665.
356. Mountcastle V.B., Andersen R.A., Motter B.C. The influence of attentive fixation upon the excitability of the light-sensitive neurons of the posterior parietal cortex. J. Neurosci. 1:1981;1218-1225.
357. Mouradian R.D., Sessler F.M., Waterhouse B.D. Noradrenergic potentiation of excitatory transmitter action in cerebrocortical slices: evidence for mediation by an alpha 1 receptor-linked second messenger pathway. Brain Res. 546:1991;83-95.
358. Mueller A.L., Palmer M.R., Hoffer B.J., Dunwiddie T.V. Hippocampal noradrenergic responses in vivo and in vitro. Characterization of alpha and beta components. Naunyn Schmiedebergs Arch. Pharmacol. 318:1982;259-266.
359. Mukhametov L.M., Rizzolatti G., Tradardi V. Spontaneous activity of neurones of nucleus reticularis thalami in freely moving cats. J. Physiol. 210:1970;651-667.
360. Murugaiah K.D., O'Donnell J.M. Clenbuterol increases norepinephrine release from rat brain slices by a calcium- and receptor-independent mechanism. Res. Commun. Mol. Pathol. Pharmacol. 86:1994;311-324.
361. Murugaiah K.D., O'Donnell J.M. Beta adrenergic receptors facilitate norepinephrine release from rat hypothalamic and hippocampal slices. Res. Commun. Mol. Pathol. Pharmacol. 90:1995;179-190.
362. Nicholas A.P., Pieribone V., Hokfelt T. Distributions of mRNAs for alpha-2 adrenergic receptor subtypes in rat brain: an in situ hybridization study. J. Comp. Neurol. 328:1993;575-594.
363. Nicholas A.P., Pieribone V.A., Hokfelt T. Cellular localization of messenger RNA for beta-1 and beta-2 adrenergic receptors in rat brain: an in situ hybridization study. Neuroscience. 56:1993;1023-1039.
364. Nisenbaum L.K., Zigmond M.J., Sved A.F., Abercrombie E.D. Prior exposure to chronic stress results in enhanced synthesis and release of hippocampal norepinephrine in response to a novel stressor. J. Neurosci. 11:1991;1478-1484.
365. Numann R., Catterall W.A., Scheuer T. Functional modulation of brain sodium channels by protein kinase C phosphorylation. Science. 254:1991;115-118.
366. O'Donnell J.M. Effect of the beta-2 adrenergic agonist zinterol on norepinephrine turnover. Res. Commun. Chem. Pathol. Pharmacol. 80:1993;113-116.
367. O'Neal H.A., Van Hoomissen J.D., Holmes P.V., Dishman R.K. Prepro-galanin messenger RNA levels are increased in rat locus coeruleus after treadmill exercise training. Neurosci. Lett. 299:2001;69-72.
368. O'Rourke M.F., Blaxall H.S., Iversen L.J., Bylund D.B. Characterization of [3H]RX821002 binding to alpha-2 adrenergic receptor subtypes. J. Pharmacol. Exp. Ther. 268:1994;1362-1367.
369. Oke A.F., Adams R.N. Selective attention dysfunctions in adult rats neonatally treated with 6-hydoxydopamine. Pharmacol. Biochem. Behav. 9:1978;429-432.
370. Olpe H.R., Steinmann M. Responses of locus coeruleus neurons to neuropeptides. Prog. Brain Res. 88:1991;241-248.
371. Packard M.G., Cahill L., McGaugh J.L. Amygdala modulation of hippocampal-dependent and caudate nucleus-dependent memory processes. Proc. Natl. Acad. Sci. U.S.A. 91:1994;8477-8481.
372. Page M.E., Abercrombie E.D. Discrete local application of corticotropin-releasing factor increases locus coeruleus discharge and extracellular norepinephrine in rat hippocampus. Synapse. 33:1999;304-313.
373. Page M.E., Akaoka H., Aston-Jones G., Valentino R.J. Bladder distention activates noradrenergic locus coeruleus neurons by an excitatory amino acid mechanism. Neuroscience. 51:1992;555-563.
374. Page M.E., Berridge C.W., Foote S.L., Valentino R.J. Corticotropin-releasing factor in the locus coeruleus mediates EEG activation associated with hypotensive stress. Neurosci. Lett. 164:1993;81-84.
375. Page M.E., Valentino R.J. Locus coeruleus activation by physiological challenges. Brain Res. Bull. 35:1994;557-560.
376. Palamarchouk V.S., Zhang J., Zhou G., Swiergiel A.H., Dunn A.J. Hippocampal norepinephrine-like voltammetric responses following infusion of corticotropin-releasing factor into the locus coeruleus. Brain Res. Bull. 51:2000;319-326.
377. Papas S., Bourque C.W. Galanin inhibits continuous and phasic firing in rat hypothalamic magnocellular neurosecretory cells. J. Neurosci. 17:1997;6048-6056.
378. Pape H.C., McCormick D.A. Noradrenaline and serotonin selectively modulate thalamic burst firing by enhancing a hyperpolarization-activated cation current. Nature. 340:1989;715-718.
379. Parasuraman R. The psychobiology of sustained attention. Warm J.S. Sustained Attention in Human Performance. 1984;61-101 John Wiley & Sons, New York.
380. Pavcovich L.A., Cancela L.M., Volosin M., Molina V.A., Ramirez O.A. Chronic stress-induced changes in locus coeruleus neuronal activity. Brain Res. Bull. 24:1990;293-296.
381. Peterson D.I., Hardinge M.G. The effect of various environmental factors on cocaine and eph edrine toxicity. J. Pharm. Pharmacol. 19:1967;810-814.
382. Peyron C., Faraco J., Rogers W., Ripley B., Overeem S., Charnay Y., Nevsimalova S., Aldrich M., Reynolds D., Albin R., Li R., Hungs M., Pedrazzoli M., Padigaru M., Kucherlapati M., Fan J., Maki R., Lammers G.J., Bouras C., Kucherlapati R., Nishino S., Mignot E. A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains. Nat. Med. 6:2000;991-997.
383. Peyron C., Tighe D.K., van Den Pol A.N., de Lecea L., Heller H.C., Sutcliffe J.G., Kilduff T.S. Neurons containing hypocretin (orexin) project to multiple neuronal systems. J. Neurosci. 18:1998;9996-10015.
384. Pfingst B.E., O'Connor T.A., Miller J.M. Response plasticity of neurons in auditory cortex of the rhesus monkey. Exp. Brain Res. 29:1977;393-404.
385. Phelps C.H. Barbiturate-induced glycogen accumulation in brain. An electron microscopic study. Brain Res. 39:1972;225-234.
386. Pickel V.M., Joh T.H., Reis D.J. A serotonergic innervation of noradrenergic neurons in nucleus locus coeruleus: demonstration by immunocytochemical localization of the transmitter specific enzymes tyrosine and tryptophan hydroxylase. Brain Res. 131:1977;197-214.
387. Pieribone V.A., Nicholas A.P., Dagerlind A., Hokfelt T. Distribution of alpha 1 adrenoceptors in rat brain revealed by in situ hybridization experiments utilizing subtype-specific probes. J. Neurosci. 14:1994;4252-4268.
388. Pieribone V.A., Xu Z.Q., Zhang X., Grillner S., Bartfai T., Hokfelt T. Galanin induces a hyperpolarization of norepinephrine-containing locus coeruleus neurons in the brainstem slice. Neuroscience. 64:1995;861-874.
389. Pineda J.A., Foote S.L., Neville H.J. The effects of locus coeruleus lesions on a squirrel monkey late positive component: a preliminary study. Electroencephalogr. Clin. Neurophysiol. Suppl. 40:1987;481-486.
390. Pineda J.A., Foote S.L., Neville H.J. Effects of locus coeruleus lesions on auditory, long-latency, event-related potentials in monkey. J. Neurosci. 9:1989;81-93.
391. Pineda J.A., Holmes T.C., Swick D., Foote S.L. Brain-stem auditory evoked potentials in squirrel monkey (Saimiri sciureus). Electroencephalogr. Clin. Neurophysiol. 73:1989;532-543.
392. Piper D.C., Upton N., Smith M.I., Hunter A.J. The novel brain neuropeptide, orexin-A, modulates the sleep-wake cycle of rats. Eur. J. Neurosci. 12:2000;726-730.
393. Pitts D.K., Marwah J. Electrophysiological effects of cocaine on central monoaminergic neurons. Eur. J. Pharmacol. 131:1986;95-98.
394. Pitts D.K., Marwah J. Cocaine inhibition of locus coeruleus neurons. NIDA Res. Monogr. 76:1987;334-340.
395. Pitts D.K., Marwah J. Electrophysiological actions of cocaine on noradrenergic neurons in rat locus ceruleus. J. Pharmacol. Exp. Ther. 240:1987;345-351.
396. Platt J.E., Stone E.A. Chronic restraint stress elicits a positive antidepressant response on the forced swim test. Eur. J. Pharmacol. 82:1982;179-181.
397. Pliszka S.R. New developments in psychopharmacology of attention deficit hyperactivity disorder. Expert. Opin. Investig. Drugs. 10:2001;1797-1807.
398. Poisbeau P., Cheney M.C., Browning M.D., Mody I. Modulation of synaptic GABAA receptor function by PKA and PKC in adult hippocampal neurons. J. Neurosci. 19:1999;674-683.
399. Poitras D., Parent A. Atlas of the distribution of monoamine-containing nerve cell bodies in the brain stem of the cat. J. Comp. Neurol. 179:1978;699-717.
400. Pompeiano O., Horn E., d'Ascanio P. Locus coeruleus and dorsal pontine reticular influences on the gain of vestibulospinal reflexes. Prog. Brain Res. 88:1991;435-462.
401. Porter N.M., Twyman R.E., Uhler M.D., Macdonald R.L. Cyclic AMP-dependent protein kinase decreases GABAA receptor current in mouse spinal neurons. Neuron. 5:1990;789-796.
402. Przybyslawski J., Roullet P., Sara S.J. Attenuation of emotional and nonemotional memories after their reactivation: role of beta adrenergic receptors. J. Neurosci. 19:1999;6623-6628.
403. Quartermain D. The role of catecholamines in memory processing. Deutsch J.A. The Physiological Basis of Memory. 1983;Wiley, New York.
404. Quirarte G.L., Roozendaal B., McGaugh J.L. Glucocorticoid enhancement of memory storage involves noradrenergic activation in the basolateral amygdala. Proc. Natl. Acad. Sci. U.S.A. 94:1997;14048-14053.
405. Ragozzino M.E., Gold P.E. Glucose injections into the medial septum reverse the effects of intraseptal morphine infusions on hippocampal acetylcholine output and memory. Neuroscience. 68:1995;981-988.
406. Rainbow T.C., Biegon A. Quantitative autoradiography of [3H]prazosin binding sites in rat forebrain. Neurosci. Lett. 40:1983;221-226.
407. Rainbow T.C., Parsons B., Wolfe B.B. Quantitative autoradiography of beta 1- and beta 2-adrenergic receptors in rat brain. Proc. Natl. Acad. Sci. U.S.A. 81:1984;1585-1589.
408. Rajkowski J., Kubiak P., Aston-Jones G. Locus coeruleus activity in monkey: phasic and tonic changes are associated with altered vigilance. Brain Res. Bull. 35:1994;607-616.
409. Ramesh V., Kumar V.M. The role of alpha-2 receptors in the medial preoptic area in the regulation of sleep-wakefulness and body temperature. Neuroscience. 85:1998;807-817.
410. Ramesh V., Kumar V.M., John J., Mallick H. Medial preoptic alpha-2 adrenoceptors in the regulation of sleep-wakefulness. Physiol. Behav. 57:1995;171-175.
411. Rasmussen K. Afferent effects on locus coeruleus in opiate withdrawal. Prog. Brain Res. 88:1991;207-216.
412. Rasmussen K., Aghajanian G.K. Serotonin excitation of facial motoneurons: receptor subtype characterization. Synapse. 5:1990;324-332.
413. Rasmussen K., Beitner-Johnson D.B., Krystal J.H., Aghajanian G.K., Nestler E.J. Opiate withdrawal and the rat locus coeruleus: behavioral, electrophysiological, and biochemical correlates. J. Neurosci. 10:1990;2308-2317.
414. Redmond D.E. Jr., Huang Y.H. Current concepts. II. New evidence for a locus coeruleus-norepinephrine connection with anxiety. Life Sci. 25:1979;2149-2162.
415. Robbins T.W. Cortical noradrenaline, attention and arousal. Psychol. Med. 14:1984;13-21.
416. Roberts D.C., Zis A.P., Fibiger H.C. Ascending catecholamine pathways and amphetamine-induced locomotor activity: importance of dopamine and apparent non-involvement of norepinephrine. Brain Res. 93:1975;441-454.
417. Robinson T.E., Castaneda E., Whishaw I.Q. Compensatory changes in striatal dopamine neurons following recovery from injury induced by 6-OHDA or methamphetamine: a review of evidence from microdialysis studies. Can. J. Psychol. 44:1990;253-275.
418. Robinson T.E., Mocsary Z., Camp D.M., Whishaw I.Q. Time course of recovery of extracellular dopamine following partial damage to the nigrostriatal dopamine system. J. Neurosci. 14:1994;2687-2696.
419. Robinson T.E., Whishaw I.Q. Normalization of extracellular dopamine in striatum following recovery from a partial unilateral 6-OHDA lesion of the substantia nigra: a microdialysis study in freely moving rats. Brain Res. 450:1988;209-224.
420. Rogawski M.A., Aghajanian G.K. Activation of lateral geniculate neurons by norepinephrine: mediation by an alpha-adrenergic receptor. Brain Res. 182:1980;345-359.
421. Rogawski M.A., Aghajanian G.K. Modulation of lateral geniculate neurone excitability by noradrenaline microiontophoresis or locus coeruleus stimulation. Nature. 287:1980;731-734.
422. Rossie S., Catterall W.A. Cyclic-AMP-dependent phosphorylation of voltage-sensitive sodium channels in primary cultures of rat brain neurons. J. Biol. Chem. 262:1987;12735-12744.
423. Rutter J.J., Baumann M.H., Waterhouse B.D. Systemically administered cocaine alters stimulus-evoked responses of thalamic somatosensory neurons to perithreshold vibrissae stimulation. Brain Res. 798:1998;7-17.
424. Sara S.J. The locus coeruleus and cognitive function: Attempts to relate noradrenergic enhancement of signal/noise in the brain to behavior. Physiol. Psychology. 13:1985;151-162.
425. Sarter M., Bruno J.P. Cortical cholinergic inputs mediating arousal, attentional processing and dreaming: differential afferent regulation of the basal forebrain by telencephalic and brainstem afferents. Neuroscience. 95:2000;933-952.
426. Sato H., Fox K., Daw N.W. Effect of electrical stimulation of locus coeruleus on the activity of neurons in the cat visual cortex. J. Neurophysiol. 62:1989;946-958.
427. Sato H., Kayama Y. Effects of noradrenaline applied iontophoretically on rat superior collicular neurons. Brain Res. Bull. 10:1983;453-457.
428. Sawaguchi T. Attenuation of delay-period activity of monkey prefrontal neurons by an alpha2-adrenergic antagonist during an oculomotor delayed-response task. J. Neurophysiol. 80:1998;2200-2205.
429. Scheel-Kruger J., Braestrup C., Nielsen M., Golembiowski R., Mogilnicka E. Cocaine: discussion of the role of dopamine in the biochemical mechanism of action. Ellinwood E.H., Kilbey M.M. Cocaine and Other Stimulants. 1977;373-407 Plenum Press, New York.
430. Schneider J.S., Kovelowski C.J. Chronic exposure to low doses of MPTP. I. Cognitive deficits in motor asymptomatic monkeys. Brain Res. 519:1990;122-128.
431. Schofield P.R., Shivers B.D., Seeburg P.H. The role of receptor subtype diversity in the CNS. Trends Neurosci. 13:1990;8-11.
432. Schuerger R.J., Balaban C.D. Immunohistochemical demonstration of regionally selective projections from locus coeruleus to the vestibular nuclei in rats. Exp. Brain Res. 92:1993;351-359.
433. Schuerger R.J., Balaban C.D. Organization of the coeruleo-vestibular pathway in rats, rabbits, and monkeys. Brain Res. Brain Res. Rev. 30:1999;189-217.
434. Segal I.S., Vickery R.G., Walton J.K., Doze V.A., Maze M. Dexmedetomidine diminishes halothane anesthetic requirements in rats through a postsynaptic alpha 2 adrenergic receptor. Anesthesiology. 69:1988;818-823.
435. Segal M., Bloom F.E. The action of norepinephrine in the rat hippocampus. II. Activation of the input pathway. Brain Res. 72:1974;99-114.
436. Segal M., Markram H., Richter-Levin G. Actions of norepinephrine in the rat hippocampus. Prog. Brain Res. 88:1991;323-330.
437. Selden N.R., Everitt B.J., Robbins T.W. Telencephalic but not diencephalic noradrenaline depletion enhances behavioural but not endocrine measures of fear conditioning to contextual stimuli. Behav. Brain Res. 43:1991;139-154.
438. Selden N.R., Robbins T.W., Everitt B.J. Enhanced behavioral conditioning to context and impaired behavioral and neuroendocrine responses to conditioned stimuli following ceruleocortical noradrenergic lesions: support for an attentional hypothesis of central noradrenergic function. J. Neurosci. 10:1990;531-539.
439. Servan-Schreiber D., Printz H., Cohen J.D. A network model of catecholamine effects: gain, signal-to-noise ratio, and behavior. Science. 249:1990;892-895.
440. Sessler F.M., Grady S.M., Waterhouse B.D., Moises H.C. Electrophysiological actions of VIP in rat somatosensory cortex. Peptides. 12:1991;715-721.
441. Sessler F.M., Liu W., Kirifides M.L., Mouradian R.D., Lin R.C., Waterhouse B.D. Noradrenergic enhancement of GABA-induced input resistance changes in layer V regular spiking pyramidal neurons of rat somatosensory cortex. Brain Res. 675:1995;171-182.
442. Sessler F.M., Mouradian R.D., Cheng J.T., Yeh H.H., Liu W.M., Waterhouse B.D. Noradrenergic potentiation of cerebellar Purkinje cell responses to GABA: evidence for mediation through the beta-adrenoceptor-coupled cyclic AMP system. Brain Res. 499:1989;27-38.
443. Shaham Y., Highfield D., Delfs J., Leung S., Stewart J. Clonidine blocks stress-induced reinstatement of heroin seeking in rats: an effect independent of locus coeruleus noradrenergic neurons. Eur. J. Neurosci. 12:2000;292-302.
444. Y. Shaham, U. Shalev, L. Lu, H. De Wit, J. Stewart, The reinstatement model of drug relapse: history, methodology and major findings, Psychopharmacology (Berl.) (2002), elec. pub. Oct. 26, 2002, PMID 12402102.
445. Sherin J.E., Shiromani P.J., McCarley R.W., Saper C.B. Activation of ventrolateral preoptic neurons during sleep. Science. 271:1996;216-219.
446. Shipley M.T., Fu L., Ennis M., Liu W.L., Aston-Jones G. Dendrites of locus coeruleus neurons extend preferentially into two pericoerulear zones. J. Comp. Neurol. 365:1996;56-68.
447. Sibley D.R., Strasser R.H., Benovic J.L., Daniel K., Lefkowitz R.J. Phosphorylation/dephosphorylation of the beta-adrenergic receptor regulates its functional coupling to adenylate cyclase and subcellular distribution. Proc. Natl. Acad. Sci. U.S.A. 83:1986;9408-9412.
448. Siggins G.R., Henriksen S.J., Chavkin C., Gruol D. Opioid peptides and epileptogenesis in the limbic system: cellular mechanisms. Adv. Neurol. 44:1986;501-512.
449. Simon H. Dopaminergic A10 neurons and frontal system (author's transl.). J. Physiol. (Paris). 77:1981;81-95.
450. Simpson K.L., Altman D.W., Wang L., Kirifides M.L., Lin R.C., Waterhouse B.D. Lateralization and functional organization of the locus coeruleus projection to the trigeminal somatosensory pathway in rat. J. Comp. Neurol. 385:1997;135-147.
451. Simpson K.L., Waterhouse B.D., Lin R.C. Origin, distribution, and morphology of galaninergic fibers in the rodent trigeminal system. J. Comp. Neurol. 411:1999;524-534.
452. Sirviö J., Riekkinen P. Jr., Vajanto I., Koivisto E., Riekkinen P.J. The effects of guanfacine, alpha-2 agonist, on the performance of young and aged rats in spatial navigation task. Behav. Neural Biol. 56:1991;101-107.
453. Skofitsch G., Jacobowitz D.M. Immunohistochemical mapping of galanin-like neurons in the rat central nervous system. Peptides. 6:1985;509-546.
454. Skolnick P., Stalvey L.P., Daly J.W., Hoyler E., Davis J.N. Binding of alpha-and beta-adrenergic ligands to cerebral cortical membranes: effect of 6-hydroxydopamine treatment and relationship to the responsiveness of cyclic amp-generating systems in two rat strains. Eur. J. Pharmacol. 47:1978;201-210.
455. Sluka K.A., Westlund K.N. Spinal projections of the locus coeruleus and the nucleus subcoeruleus in the Harlan and the Sasco Sprague-Dawley rat. Brain Res. 579:1992;67-73.
456. Sly J.D., Colvill L., McKinley J.M., Oldfield J.B. Identification of neural projections from the forebrain to the kidney, using the virus pseudorabies. J. Auton. Nerv. Syst. 77:1999;73-82.
457. Smagin G.N., Swiergiel A.H., Dunn A.J. Corticotropin-releasing factor administered into the locus coeruleus, but not the parabrachial nucleus, stimulates norepinephrine release in the prefrontal cortex. Brain Res. Bull. 36:1995;71-76.
458. Smythe J.W., Cristie B.R., Colom L.V., Lawson V.H., Bland B.H. Hippocampal theta field activity and theta-on/theta-off cell discharges are controlled by an ascending hypothalamo-septal pathway. J. Neurosci. 11:1991;2241-2248.
459. Snoddy A.M., Tessel R.E. Prazosin: effect on psychomotor-stimulant cues and locomotor activity in mice. Eur. J. Pharmacol. 116:1985;221-228.
460. Solanto M.V. Attention-deficit/hyperactivity disorder. Solanto M.V., Arnsten A.F.T., Castellanos F.X. Stimulant Drugs and ADHD: Basic and Clinical Neuroscience. 2001;3-30 Oxford University Press, New York.
461. Sood S., Dhawan J.K., Ramesh V., John J., Gopinath G., Kumar V.M. Role of medial preoptic area beta adrenoceptors in the regulation of sleep-wakefulness. Pharmacol. Biochem. Behav. 57:1997;1-5.
462. Sorg O., Magistretti P.J. Characterization of the glycogenolysis elicited by vasoactive intestinal peptide, noradrenaline and adenosine in primary cultures of mouse cerebral cortical astrocytes. Brain Res. 563:1991;227-233.
463. Sorg O., Magistretti P.J. Vasoactive intestinal peptide and noradrenaline exert long-term control on glycogen levels in astrocytes: blockade by protein synthesis inhibition. J. Neurosci. 12:1992;4923-4931.
464. Southwick S.M., Bremner J.D., Rasmusson A., Morgan C.A., III A. Arnsten, D.S. Charney, Role of norepinephrine in the pathophysiology and treatment of posttraumatic stress disorder. Biol. Psychiatry. 46:1999;1192-1204.
465. Southwick S.M., Krystal J.H., Morgan C.A., Johnson D., Nagy L.M., Nicolaou A., Heninger G.R., Charney D.S. Abnormal noradrenergic function in posttraumatic stress disorder. Arch. Gen. Psychiatry. 50:1993;266-274.
466. Sporn J.R., Wolfe B.B., Harden T.K., Molinoff P.B. Supersensitivity in rat cerebral cortex: pre- and postsynaptic effects of 6-hydroxydopamine at noradrenergic synapses. Mol. Pharmacol. 13:1977;1170-1180.
467. Stanton P.K., Sarvey J.M. Depletion of norepinephrine, but not serotonin, reduces long-term potentiation in the dentate gyrus of rat hippocampal slices. J. Neurosci. 5:1985;2169-2176.
468. Stanton P.K., Sarvey J.M. Norepinephrine regulates long-term potentiation of both the population spike and dendritic EPSP in hippocampal dentate gyrus. Brain Res. Bull. 18:1987;115-119.
469. Steere J.C., Arnsten A.F. The alpha-2A noradrenergic receptor agonist guanfacine improves visual object discrimination reversal performance in aged rhesus monkeys. Behav. Neurosci. 111:1997;883-891.
470. Steindler D.A. Locus coeruleus neurons have axons that branch to the forebrain and cerebellum. Brain Res. 223:1981;367-373.
471. Stelzer A., Kay A.R., Wong R.K. GABAA-receptor function in hippocampal cells is maintained by phosphorylation factors. Science. 241:1988;339-341.
472. Steriade M. Alterations of evoked neuronal discharges in motor and somesthetic cortices during the sleep-wakefulness cycles in the monkey. Electroencephalogr. Clin. Neurophysiol. 27:1969;678.
473. Steriade M., Buzsaki G. Parallel Activation of Thalamic and Cortical Neurons By Brainstem and Basal Forebrain Cholinergic Systems. 1990;Oxford University Press, Oxford.
474. Steriade M., Domich L., Oakson G. Reticularis thalami neurons revisited: activity changes during shifts in states of vigilance. J. Neurosci. 6:1986;68-81.
475. Sterman M.B., Clemente C.D. Forebrain inhibitory mechanisms: cortical synchronization induced by basal forebrain stimulation. Exp. Neurol. 6:1962;91-102.
476. Stevens K.E., Fuller L.L., Rose G.M. Dopaminergic and noradrenergic modulation of amphetamine-induced changes in auditory gating. Brain Res. 555:1991;91-98.
477. Still G.F. Some abnormal psychical conditions in children. Lancet. 1:1902;1008-1012.
478. Stone E.A. Accumulation and metabolism of norepinephrine in rat hypothalamus after exhaustive stress. J. Neurochem. 21:1973;589-601.
479. Stone E.A. Neurochemical and behavioral effects of severe stress. Psychopharmacol. Bull. 11:1975;71-72.
480. Stone E.A. Reduction by stress of norepinephrine-stimulated accumulation of cyclic AMP in rat cerebral cortex. J. Neurochem. 32:1979;1335-1337.
481. Stone E.A. Mechanism of stress-induced subsensitivity to norepinephrine. Pharmacol. Biochem. Behav. 14:1981;719-723.
482. Stone E.A. Adaptation to stress and brain noradrenergic receptors. Neurosci. Biobehav. Rev. 7:1983;503-509.
483. Stone E.A. Problems with current catecholamine hypotheses of antidepressant agents: Speculations leading to a new hypothesis. Behav. Brain Sci. 6:1983;535-577.
484. Stone E.A. Central cyclic-AMP-linked noradrenergic receptors: new findings on properties as related to the actions of stress. Neurosci. Biobehav. Rev. 11:1987;391-398.
485. Stone E.A., Ariano M.A. Are glial cells targets of the central noradrenergic system? A review of the evidence. Brain Res. Brain Res. Rev. 14:1989;297-309.
486. Stone E.A., Freedman L.S., Morgano L.E. Brain and adrenal tyrosine hydroxylase activity after chronic footshock stress. Pharmacol. Biochem. Behav. 9:1978;551-553.
487. Stone E.A., John S.M. Further evidence for a glial localization of rat cortical beta-adrenoceptors: studies of in vivo cyclic AMP responses to catecholamines. Brain Res. 549:1991;78-82.
488. Stone E.A., Platt J.E., Herrera A.S., Kirk K.L. Effect of repeated restraint stress, desmethylimipramine or adrenocorticotropin on the alpha and beta adrenergic components of the cyclic AMP response to norepinephrine in rat brain slices. J. Pharmacol. Exp. Ther. 237:1986;702-707.
489. Stone E.A., Platt J.E., Trullas R., Slucky A.V. Reduction of the cAMP response to norepinephrine in rat cerebral cortex following repeated restraint stress. Psychopharmacology (Berl.). 82:1984;403-405.
490. Stone E.A., Quartermain D. Alpha-1-noradrenergic neurotransmission, corticosterone, and behavioral depression. Biol. Psychiatry. 46:1999;1287-1300.
491. Stone E.A., Sessler F.M., Liu W.M. Glial localization of adenylate-cyclase-coupled beta-adrenoceptors in rat forebrain slices. Brain Res. 530:1990;295-300.
492. Stone E.A., Slucky A.V., Platt J.E., Trullas R. Reduction of the cyclic adenosine 3′,5′-monophosphate response to catecholamines in rat brain slices after repeated restraint stress. J. Pharmacol. Exp. Ther. 233:1985;382-388.
493. Stone E.A., Zhang Y. Adrenoceptor antagonists block c-fos response to stress in the mouse brain. Brain Res. 694:1995;279-286.
494. Stone E.A., Zhang Y., Hiller J.M., Simon E.J., Hillman D.E. Activation of fos in mouse amygdala by local infusion of norepinephrine or atipamezole. Brain Res. 778:1997;1-5.
495. Stone E.A., Zhang Y., John S., Filer D., Bing G. Effect of locus coeruleus lesion on c-fos expression in the cerebral cortex caused by yohimbine injection or stress. Brain Res. 603:1993;181-185.
496. Stone E.A., Zhang Y., John S.M., Bing G. c-Fos response to administration of catecholamines into brain by microdialysis. Neurosci. Lett. 133:1991;33-35.
497. Stone T.W. Pharmacology of pyramidal tract cells in the cerebral cortex. Naunyn Schmiedebergs Arch. Pharmacol. 278:1973;333-346.
498. Sullivan G.M., Coplan J.D., Kent J.M., Gorman J.M. The noradrenergic system in pathological anxiety: a focus on panic with relevance to generalized anxiety and phobias. Biol. Psychiatry. 46:1999;1205-1218.
499. Sulser F. Functional aspects of the norepinephrine receptor coupled adenylate cyclase system in the limbic forebrain and its modification by drugs which precipitate or alleviate depression: molecular approaches to an understanding of affective disorders. Pharmakopsychiatr. Neuropsychopharmakol. 11:1978;43-52.
500. Sulser F., Vetulani J., Mobley P.L. Mode of action of antidepressant drugs. Biochem. Pharmacol. 27:1978;257-261.
501. Swanson L.W. The locus coeruleus: a cytoarchitectonic, Golgi and immunohistochemical study in the albino rat. Brain Res. 110:1976;39-56.
502. Swanson L.W., Cowan W.M. An autoradiographic study of the organization of the efferent connections of the hippocampal formation in the rat. J. Comp. Neurol. 172:1977;49-84.
503. Swanson L.W., Cowan W.M. The connections of the septal region in the rat. Comp. Neurol. 186:1979;621-656.
504. Swanson L.W., Hartman B.K. The central adrenergic system. An immunofluorescence study of the location of cell bodies and their efferent connections in the rat utilizing dopamine-beta-hydroxylase as a marker. J. Comp. Neurol. 163:1975;467-505.
505. Swanson L.W., Sawchenko P.E., Rivier J., Vale W.W. Organization of ovine corticotropin-releasing factor immunoreactive cells and fibers in the rat brain: an immunohistochemical study. Neuroendocrinology. 36:1983;165-186.
506. Sweetnam P.M., Lloyd J., Gallombardo P., Malison R.T., Gallager D.W., Tallman J.F., Nestler E.J. Phosphorylation of the GABAa/benzodiazepine receptor alpha subunit by a receptor-associated protein kinase. J. Neurochem. 51:1988;1274-1284.
507. Swick D., Pineda J.A., Foote S.L. Effects of systemic clonidine on auditory event-related potentials in squirrel monkeys. Brain Res. Bull. 33:1994;79-86.
508. Swiergiel A.H., Takahashi L.K., Rubin W.W., Kalin N.H. Antagonism of corticotropin-releasing factor receptors in the locus coeruleus attenuates shock-induced freezing in rats. Brain Res. 587:1992;263-268.
509. Tanila H., Rama P., Carlson S. The effects of prefrontal intracortical microinjections of an alpha-2 agonist, alpha-2 antagonist and lidocaine on the delayed alternation performance of aged rats. Brain Res. Bull. 40:1996;117-119.
510. Thakkar M.M., Ramesh V., Strecker R.E., McCarley R.W. Microdialysis perfusion of orexin-A in the basal forebrain increases wakefulness in freely behaving rats. Arch. Ital. Biol. 139:2001;313-328.
511. Thannickal T.C., Moore R.Y., Nienhuis R., Ramanathan L., Gulyani S., Aldrich M., Cornford M., Siegel J.M. Reduced number of hypocretin neurons in human narcolepsy [In Process Citation]. Neuron. 27:2000;469-474.
512. Thierry A.M., Javoy F., Glowinski J., Kety S.S. Effects of stress on the metabolism of norepinephrine, dopamine and serotonin in the central nervous system of the rat. I. Modifications of norepinephrine turnover. J. Pharmacol. Exp. Ther. 163:1968;163-171.
513. Timo-Iaria C., Negrao N., Schmidek W.R., Hoshino K., Lobato de Menezes C.E., Leme D.R. Phases and states of sleep in the rat. Physiol. Behav. 5:1970;1057-1062.
514. Trampus M., Ongini E. The D1 dopamine receptor antagonist SCH 23390 enhances REM sleep in the rat. Neuropharmacology. 29:1990;889-893.
515. Tseng J.Y., Kolb P.E., Raskind M.A., Miller M.A. Estrogen regulates galanin but not tyrosine hydroxylase gene expression in the rat locus ceruleus. Brain Res. Mol. Brain Res. 50:1997;100-106.
516. Usher M., Cohen J.D., Servan-Schreiber D., Rajkowski J., Aston-Jones G. The role of locus coeruleus in the regulation of cognitive performance. Science. 283:1999;549-554.
517. Valentino R.J., Aston-Jones G. Physiological determinants of locus coeruleus discharge. Bloom F.E., Kupfer D.J. Psychopharmacology: The Fourth Generation of Progress. 1995;373-385 Raven Press, New York.
518. Valentino R.J., Foote S.L. Corticotropin-releasing factor disrupts sensory responses of brain noradrenergic neurons. Neuroendocrinology. 45:1987;28-36.
519. Valentino R.J., Foote S.L. Corticotropin-releasing hormone increases tonic but not sensory-evoked activity of noradrenergic locus coeruleus neurons in unanesthetized rats. J. Neurosci. 8:1988;1016-1025.
520. Valentino R.J., Foote S.L., Aston-Jones G. Corticotropin-releasing factor activates noradrenergic neurons of the locus coeruleus. Brain Res. 270:1983;363-367.
521. Valentino R.J., Page M., Van Bockstaele E., Aston-Jones G. Corticotropin-releasing factor innervation of the locus coeruleus region: distribution of fibers and sources of input. Neuroscience. 48:1992;689-705.
522. Valentino R.J., Page M.E., Curtis A.L. Activation of noradrenergic locus coeruleus neurons by hemodynamic stress is due to local release of corticotropin-releasing factor. Brain Res. 555:1991;25-34.
523. Valentino R.J., Wehby R.G. Corticotropin-releasing factor: evidence for a neurotransmitter role in the locus ceruleus during hemodynamic stress. Neuroendocrinology. 48:1988;674-677.
524. Van Bockstaele E.J., Bajic D., Proudfit H., Valentino R.J. Topographic architecture of stress-related pathways targeting the noradrenergic locus coeruleus. Physiol. Behav. 73:2001;273-283.
525. Van Bockstaele E.J., Colago E.E., Aicher S. Light and electron microscopic evidence for topographic and monosynaptic projections from neurons in the ventral medulla to noradrenergic dendrites in the rat locus coeruleus. Brain Res. 784:1998;123-138.
526. Van Bockstaele E.J., Colago E.E., Cheng P., Moriwaki A., Uhl G.R., Pickel V.M. Ultrastructural evidence for prominent distribution of the mu-opioid receptor at extrasynaptic sites on noradrenergic dendrites in the rat nucleus locus coeruleus. J. Neurosci. 16:1996;5037-5048.
527. Van Bockstaele E.J., Colago E.E., Valentino R.J. Corticotropin-releasing factor-containing axon terminals synapse onto catecholamine dendrites and may presynaptically modulate other afferents in the rostral pole of the nucleus locus coeruleus in the rat brain. J. Comp. Neurol. 364:1996;523-534.
528. Van Bockstaele E.J., Colago E.E., Valentino R.J. Amygdaloid corticotropin-releasing factor targets locus coeruleus dendrites: substrate for the co-ordination of emotional and cognitive limbs of the stress response. J. Neuroendocrinol. 10:1998;743-757.
529. Van Bockstaele E.J., Peoples J., Telegan P. Efferent projections of the nucleus of the solitary tract to peri-locus coeruleus dendrites in rat brain: evidence for a monosynaptic pathway. J. Comp. Neurol. 412:1999;410-428.
530. Van Bockstaele E.J., Peoples J., Valentino R.J., Bennett Research Award A.E. Anatomic basis for differential regulation of the rostrolateral peri-locus coeruleus region by limbic afferents. Biol. Psychiatry. 46:1999;1352-1363.
531. Van Bockstaele E.J., Pieribone V.A., Aston-Jones G. Diverse afferents converge on the nucleus paragigantocellularis in the rat ventrolateral medulla: retrograde and anterograde tracing studies. J. Comp. Neurol. 290:1989;561-584.
532. VanderMaelen C.P., Aghajanian G.K. Intracellular studies showing modulation of facial motoneurone excitability by serotonin. Nature. 287:1980;346-347.
533. Vanderwolf C.H. Cerebral activity and behavior: control by central cholinergic and serotonergic systems. Int. Rev. Neurobiol. 30:1988;225-340.
534. Vanderwolf C.H., Robinson T.E. Reticulo-cortical activity and behavior: A critique of the arousal theory and a new synthesis. Behav. Brain Sci. 4:1981;459-514.
535. Vankov A., Herve-Minvielle A., Sara S.J. Response to novelty and its rapid habituation in locus coeruleus neurons of the freely exploring rat. Eur. J. Neurosci. 7:1995;1180-1187.
536. Vetulani J., Stawarz R.J., Dingell J.V., Sulser F. A possible common mechanism of action of antidepressant treatments: reduction in the sensitivity of the noradrenergic cyclic AMP gererating system in the rat limbic forebrain. Naunyn Schmiedebergs Arch. Pharmacol. 293:1976;109-114.
537. Videen T.O., Daw N.W., Rader R.K. The effect of norepinephrine on visual cortical neurons in kittens and adult cats. J. Neurosci. 4:1984;1607-1617.
538. Vizzard M.A., Erickson V.L., Card J.P., Roppolo J.R., de Groat W.C. Transneuronal labeling of neurons in the adult rat brainstem and spinal cord after injection of pseudorabies virus into the urethra. J. Comp. Neurol. 355:1995;629-640.
539. Walaas I., Fonnum F. Biochemical evidence for glutamate as a transmitter in hippocampal efferents to the basal forebrain and hypothalamus in the rat brain. Neuroscience. 5:1980;1691-1698.
540. Wang L.Y., Salter M.W., MacDonald J.F. Regulation of kainate receptors by cAMP-dependent protein kinase and phosphatases. Science. 253:1991;1132-1135.
541. Warm J.S., Jerison H.J. The psychophysics of vigilance. Warm J.S. Sustained Attention in Human Performance. 1984;15-59 John Wiley & Sons, New York.
542. Watanabe H., Passonneau J.V. Factors affecting the turnover of cerebral glycogen and limit dextrin in vivo. J. Neurochem. 20:1973;1543-1554.
543. Waterhouse B.D., Azizi S.A., Burne R.A., Woodward D.J. Modulation of rat cortical area 17 neuronal responses to moving visual stimuli during norepinephrine and serotonin microiontophoresis. Brain Res. 514:1990;276-292.
544. Waterhouse B.D., Border B., Wahl L., Mihailoff G.A. Topographic organization of rat locus coeruleus and dorsal raphe nuclei: distribution of cells projecting to visual system structures. J. Comp. Neurol. 336:1993;345-361.
545. Waterhouse B.D., Devilbiss D.M. Tonic locus coeruleus output and signal transfer through somatosensory cortical circuits: II. Locomotion. Soc. Neurosci. Abst. 25:1999;1121.
546. Waterhouse B.D., Lin C.S., Burne R.A., Woodward D.J. The distribution of neocortical projection neurons in the locus coeruleus. J. Comp. Neurol. 217:1983;418-431.
547. Waterhouse B.D., Moises H.C., Woodward D.J. Noradrenergic modulation of somatosensory cortical neuronal responses to iontophoretically applied putative neurotransmitters. Exp. Neurol. 69:1980;30-49.
548. Waterhouse B.D., Moises H.C., Woodward D.J. Alpha-receptor-mediated facilitation of somatosensory cortical neuronal responses to excitatory synaptic inputs and iontophoretically applied acetylcholine. Neuropharmacology. 20:1981;907-920.
549. Waterhouse B.D., Moises H.C., Woodward D.J. Phasic activation of the locus coeruleus enhances responses of primary sensory cortical neurons to peripheral receptive field stimulation. Brain Res. 790:1998;33-44.
550. Waterhouse B.D., Moises H.C., Yeh H.H., Woodward D.J. Norepinephrine enhancement of inhibitory synaptic mechanisms in cerebellum and cerebral cortex: mediation by beta adrenergic receptors. J. Pharmacol. Exp. Ther. 221:1982;495-506.
551. Waterhouse B.D., Mouradian R., Sessler F.M., Lin R.C. Differential modulatory effects of norepinephrine on synaptically driven responses of layer V barrel field cortical neurons. Brain Res. 868:2000;39-47.
552. Waterhouse B.D., Sessler F.M., Cheng J.T., Woodward D.J., Azizi S.A., Moises H.C. New evidence for a gating action of norepinephrine in central neuronal circuits of mammalian brain. Brain Res. Bull. 21:1988;425-432.
553. Waterhouse B.D., Stowe Z.N., Jimenez-Rivera C.A., Sessler F.M., Woodward D.J. Cocaine actions in a central noradrenergic circuit: enhancement of cerebellar Purkinje neuron responses to iontophoretically applied GABA. Brain Res. 546:1991;297-309.
554. Waterhouse B.D., Woodward D.J. Interaction of norepinephrine with cerebrocortical activity evoked by stimulation of somatosensory afferent pathways in the rat. Exp. Neurol. 67:1980;11-34.
555. Waterman A., Livingston A., Bouchenafa O. Analgesic effects of intrathecally-applied alpha 2-adrenoceptor agonists in conscious, unrestrained sheep. Neuropharmacology. 27:1988;213-216.
556. Weiss J.M., Bailey W.H., Pohorecky L.A., Korzeniowski D., Grillione G. Stress-induced depression of motor activity correlates with regional changes in brain norepinephrine but not in dopamine. Neurochem. Res. 5:1980;9-22.
557. Weiss J.M., Glazer H.I., Pohorecky L.A., Brick J., Miller N.E. Effects of chronic exposure to stressors on avoidance-escape behavior and on brain norepinephrine. Psychosom. Med. 37:1975;522-534.
558. Weiss J.M., Stone E.A., Harrell N. Coping behavior and brain norepinephrine level in rats. J. Comp. Physiol. Psychol. 72:1970;153-160.
559. Weiss J.M., Stout J.C., Aaron M.F., Quan N., Owens M.J., Butler P.D., Nemeroff C.B. Depression and anxiety: role of the locus coeruleus and corticotropin-releasing factor. Brain Res. Bull. 35:1994;561-572.
560. West M.O., Woodward D.J. A technique for microiontophoresis in the freely moving rat. Soc. Neurosci. Abst. 9:1983;227.
561. Westlund K.N., Bowker R.M., Ziegler M.G., Coulter J.D. Origins of spinal noradrenergic pathways demonstrated by retrograde transport of antibody to dopamine-beta-hydroxylase. Neurosci. Lett. 25:1981;243-249.
562. Westlund K.N., Bowker R.M., Ziegler M.G., Coulter J.D. Noradrenergic projections to the spinal cord of the rat. Brain Res. 263:1983;15-31.
563. Westlund K.N., Bowker R.M., Ziegler M.G., Coulter J.D. Origins and terminations of descending noradrenergic projections to the spinal cord of monkey. Brain Res. 292:1984;1-16.
564. Westlund K.N., Coulter J.D. Descending projections of the locus coeruleus and subcoeruleus/medial parabrachial nuclei in monkey: axonal transport studies and dopamine-beta-hydroxylase immunocytochemistry. Brain Res. 2:1980;235-264.
565. White F.J., Kalivas P.W. Neuroadaptations involved in amphetamine and cocaine addiction. Drug Alcohol Depend. 51:1998;141-153.
566. White S.R., Neuman R.S. Facilitation of spinal motoneurone excitability by 5-hydroxytryptamine and noradrenaline. Brain Res. 188:1980;119-127.
567. Williams C.L., McGaugh J.L. Reversible inactivation of the nucleus of the solitary tract impairs retention performance in an inhibitory avoidance task. Behav. Neural Biol. 58:1992;204-210.
568. Williams C.L., McGaugh J.L. Reversible lesions of the nucleus of the solitary tract attenuate the memory-modulating effects of posttraining epinephrine. Behav. Neurosci. 107:1993;955-962.
569. Williams C.L., Men D., Clayton E.C. The effects of noradrenergic activation of the nucleus tractus solitarius on memory and in potentiating norepinephrine release in the amygdala. Behav. Neurosci. 114:2000;1131-1144.
570. Williams C.L., Men D., Clayton E.C., Gold P.E. Norepinephrine release in the amygdala after systemic injection of epinephrine or escapable footshock: contribution of the nucleus of the solitary tract. Behav. Neurosci. 112:1998;1414-1422.
571. Wilson M.C., Bedford J.A., Buelke J., Kibbe A.H. Acute pharmacological activity of intravenous cocaine in the rhesus monkey. Psychopharmacol. Commun. 2:1976;251-261.
572. Witte E.A., Marrocco R.T. Alteration of brain noradrenergic activity in rhesus monkeys affects the alerting component of covert orienting. Psychopharmacology (Berl.). 132:1997;315-323.
573. Woods D.L., Knight R.T. Electrophysiologic evidence of increased distractibility after dorsolateral prefrontal lesions. Neurology. 36:1986;212-216.
574. Woodward D.J., Moises H.C., Waterhouse B.D., Hoffer B.J., Freedman R. Modulatory actions of norepinephrine in the central nervous system. Fed. Proc. 38:1979;2109-2116.
575. Wu M.F., Gulyani S.A., Yau E., Mignot E., Phan B., Siegel J.M. Locus coeruleus neurons: cessation of activity during cataplexy. Neuroscience. 91:1999;1389-1399.
576. Xu Z.Q., Shi T.J., Hokfelt T. Galanin. J. Comp. Neurol. 392:1998;227-251.
577. Yamaguchi N., Marczynski T.J., Ling G.M. The effects of electrical and chemical stimulation of the preoptic region and some non-specific thalamic nuclei in unrestrained, waking animals. Electroencephalogr. Clin. Neurophysiol. 15:1963;154.
578. Young W.S., III M.J. Kuhar, Noradrenergic alpha 1 and alpha 2 receptors: light microscopic autoradiographic localization. Proc. Natl. Acad. Sci. U.S.A. 77:1980;1696-1700.
579. Zaborsky L., Cullinan W.E., Braun A. Afferent to basal forebrain cholinergic projection neurons: an update. Napier T.C. The Basal Forebrain. 1991;43-100 Plenum, New York.
580. Zahm D.S., Brog J.S. On the significance of subterritories in the "accumbens" part of the rat ventral striatum. Neuroscience. 50:1992;751-767.
581. Zardetto-Smith A.M., Gray T.S. Organization of peptidergic and catecholaminergic efferents from the nucleus of the solitary tract to the rat amygdala. Brain Res. Bull. 25:1990;875-887.
582. Zigmond M.J., Harvey J.A. Resistance to central norepinephrine depletion and decreased mortality in rats chronically exposed to electric foot shock. J. Neurovisc. Relat. 31:1970;373-381.
583. Zoli M., Torri C., Ferrari R., Jansson A., Zini I., Fuxe K., Agnati L.F. The emergence of the volume transmission concept. Brain Res. Brain Res. Rev. 26:1998;136-147.
584. Zornetzer S. Applied aspects of memory research: Aging. Martinez J.L. Jr., Kesner R.P. Learning and Memory: A Biological View. 1986;203-233 Academic Press, Orlando.